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ABSTRACT 
ln anesthesia practice, consciousness is often equated with the 
waking state and with the ability ta respond ta stimuli in the integrated 
manner. The reversible loss of consciousness is induced by the general 
anesthetic, which have a wide range of molecular structure and 
physicochemical characteristics. The mechanisms of unconsciousness 
induced by anesthetic agents are not weil understood. The studies 1 have 
conducted for my Ph.D. have focused on how anesthetic drugs produce 
unconsciousness in human subjects. In two separate PET studies, 
receptor imaging and regional CBF analysis were used ta examine the 
unconsciousness induced by propofol, a popular general anesthetic. The 
first study evaluated kinetic analysis methods for estimation of the 
receptor availability of the muscarinic receptor using dynamic positron 
emission tomography (PET) studies with [N-11 C-methyl]-benztropine. The 
study also investigated the effect of propofol on central muscarinic 
receptor availability during general anesthesia. The results of this study 
suggested the propofol-related reductions in muscarinic receptor 
availability. The second study identified the brain function changes 
specifically linked ta the difference in levels of consciousness. We used 
physostigmine (an anticholinestherase) ta restore consciousness in the 
x 
subjects anesthetized with a constant concentration of propofol. The 
results revealed that the thalamus and precuneus/cuneus jointly play a 
critical role in controlling the changes in the level of consciousness during 
general anesthesia. 
Together, these two studies support a hypothesis that the joint 
deactivations of a Common Midline Core, which includes the medial 
thalamus, midline precuneus/cuneus, prefrontal cortex and other related 
cortical areas, contribute to the unconsciousness induced by general 
anesthetics. These deactivations are mediated, at least partially, by a 
reduction in the central cholinergie transmission. 
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ABRÉGÉ 
En anesthésie, la conscience est souvent définie comme l'état d'éveil, 
et comme la capacité de répondre aux stimuli simples de façon cohérente. 
La perte de conscience est induite de façon réversible par les 
anesthésiques généraux qui varient considérablement dans leurs 
structures moléculaires et leurs caractéristiques physico-chimiques. Les 
mécanismes qui sous-tendent la perte de conscience induite par les 
anesthésiques ne sont pas bien compris. Les études que j'ai menées pour 
l'obtention de mon doctorat ont pour sujet les mécanismes de production 
de l'inconscience par les anesthésiques généraux chez l'humain. Dans 
deux études distinctes avec le Tomographe à Émission de Positrons 
(TEP), l'une sur les récepteurs muscariniques et l'autre sur le débit 
sanguin régional cérebral, nous avons examiné l'inconscience produite 
par le propofol, un anesthésique général largement utilisé en clinique. 
Dans la première étude, nous avons évalué différentes méthodes 
d'analyse cinétique pour l'estimation de la disponibilité des récepteurs 
muscariniques suite à des études dynamiques au TEP avec la N 11 C-
methyl benztropine. Nous avons aussi étudié les effets du propofol sur la 
disponibilité des récepteurs muscariniques pendant l'anesthésie générale. 
Nos résultats suggèrent une diminution de la disponibilité des récepteurs 
xii 
muscariniques par la propofol. La deuxième étude porte sur les 
changements des fonctions cérébrales spécifiquement liés aux 
changements dans l'état de conscience. Nous avons utilié la physostimine 
(un agent anticholinestérasique) pour provoquer le retour de la conscience 
chez 4 sujets anesthésiés avec une concentration stable de propofol. Les 
résultats montrent que le thalamus et le cuneus/précuneus jouent 
conjointement un rôle central dans le contrôle des changements de niveau 
de conscience pendant l'anesthésie générale. 
Ces deux études supportent l'hypothèse que la désactivation du 
'Common Midline Core', qui comprend le thalamus médian, le 
cunéus/précunéus, le cortex préfrontal et dautres régions corticales, 
contribuent à l'inconscience induite par les anesthésiques généraux. Ces 
désactivations sont tributaires, au moins en partie, de la réduction de la 
transmission dans le système cholinergique central. 
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Chapter 1 GENERAL INTRODUCTION 
1.1 Consciousness 
1.1.1 Concept of consciousness 
The concept of consciousness contains a number of different 
concepts and denotes a number of different phenomena. Consciousness 
refers to many different entities and has been studied by many disciplines, 
ranging fram philosophy and cognitive science to psychology and 
neurabiology. It is not possible to pravide an all-encompassing definition of 
the term consciousness, but it would be beneficial to distinguish three 
principal meanings (Zeman et al., 1997; Zeman, 2001). 
The first meaning of consciousness, defined by Zeman, is called the 
"waking state", which describes the abilities to perceive, interact and 
communicate with the enviranment in an integrated manner. So a person 
with consciousness is awake, aroused, alert or vigilant in contrast to 
drawsiness or coma. The second meaning of consciousness defined by 
Zeman is the content of subjective experience. When we are conscious, 
we are always conscious of something that is the content of experience 
fram moment to moment. This concept of consciousness highlights the 
qualitative, subjective dimension of experience and is widely used in the 
field of philosophy. The third meaning of consciousness defined by Zeman 
2 
is synonymous with. the mind, where person with consciousness is able to 
have expressions of belief, hope, fear, intent, desire, etc. 
Most of the researches related to consciousness have focused on its 
first and second meaning, rather than this third meaning. The first 
meaning has been widely used in medical field. Medical doctors use the 
Glasgow Coma Scale to objectively define the different states of 
consciousness. In the operation room, anesthesiologists are able to 
suppress and restore the consciousness of a patient by regulating the 
concentration of anesthetic agents. 
1.1.2 Consciousness and sleep 
The physiological mechanisms that underlie consciousness and 
unconsciousness are the sleep-wake mechanisms, as sleep is a state of 
physiological reversible unconsciousness. The process about how the 
brain transfers from sleep to wakefulness was explored by Morruzzi and 
Magoun (1949). They demonstrated that a cut through the mid-brain of a 
cat at a high level resulted in a state of continuous slow wave sleep, while 
a slightly lower cut produced a state of continuous wakefulness. Moreover, 
stimulating the mid-brain near the central canal in the sleeping cat resulted 
in immediate wakefulness and activated EEG. Those observations gave 
3 
birth to the concept of the reticular activating mechanism that a column of 
cells surrounding the central canal, the mid-brain reticular substance, 
received input from ail the ascending tracts of the brain stem (Figure 1-1). 
This activity could be relayed to the entire cortex through thalamus 
resulting in wakefulness with general cortical activation. Their work has 
been repeated and confirmed (Sinton and McCarley, 2000). Further 
animal experimental studies identified that a series of specialized nodes 
also play important roles in the maintenance and modulation of 
wakefulness, which includes basal forebrain, caudate, subthalamus, and 
hypothalamus (Figure 1-2) (Jones, 1998; Zeman, 2001). 
The transition from wakefulness to sleep is less weil known. Recent 
evidence suggests that there is an arousal inhibitory mechanism (AIM), 
which transfers the brain from wakefulness to sleep by a thalamo-cortial 
mechanism. McCarley (2004) and Steriade (2004) studied sleep onset in 
both cat and man. They demonstrated that at the onset of drowsiness, 
sleep spindles appear in the thalamus and later spread to involve the 
cortex. Using positron emission tomography (PET), Maquet (2000) studied 
wakefulness and sleep. He found that there was a much lower blood flow 
in the thalamus and upper brain stem than elsewhere 
Thalamus 
Upper 
brainstem 
reticular 
formation 
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Figure 1-1: The reticular activating system 
A schematic diagram of the reticular activating system, indicating 
pathways of activation which involve and those which bypass the 
thalamus (From Zeman 1997) 
5 
Figure 1-2: A sagittal drawing of a cat brain indicating the structure 
implicated in generating and maintaining the waking states 
sc 
A capital drawing of a cat brain indicating the structure implicated in 
generating and maintaining the waking states. Areas marked with a W are 
those fram where ceUs are maximaUy active during wakefulness. Area 
encircled by dashed lines in bold are those where selective lesions most 
commonly cause coma. AC= anterior commissure; CS = cerebellum; CC = 
corpus callosum; Hi = hippocampus, OB = olfactory bulb; or = optic tracts; 
sc = spinal cord (From Jones, 1998). 
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during deep sleep. This finding strongly supports those of Steriade in the 
demonstration of a deactivating process at the thalamic level in slow wave 
sleep and the presence of an AIM. 
1.1.3 Consciousness and anesthesia 
ln neurological and anesthesia practice, consciousness is often 
equated with the waking state, and with the ability to respond to stimuli in 
an integrated manner associated with this state. Arousal is necessary for 
the emergence of consciousness. Those aspects of consciousness are 
partially depressed or totally lost during anesthesia and regained after 
anesthesia. The reversible loss of consciousness is induced by the 
hypnotic or general anesthetic agents, which have a wide range of 
molecular structure and physicochemical characteristics. The mechanisms 
of unconsciousness induced by anesthetic agents are not weil understood. 
Since Meyer and Overton (Meyer et al. 1899) discovered a correlation 
between anesthetic potency and partitioning into fat-Iike solvents (oil/gas 
partition coefficient), the traditional view had been that general anesthetics 
act by disrupting the structure or dynamic properties of the Iipid portions of 
nerve membranes. However, by the early 1980s, accumulating evidence 
posed serious quantitative problems for this simple unifying idea. Taken 
7 
together with positive evidence for the direct involvement of proteins, this 
has led to the almost complete abandonment of theories that postulate 
changes in the properties of the bulk lipid bilayer (Franks et al, 1984, 
1987). The available evidence strongly suggests that general anesthetics 
act by binding directly to proteins and probably exert their primary effects 
at a relatively small number of CNS targets (Franks et al. 1991,1994, 
1998). These are most likely to be postsynaptic ligand-gated ion channels. 
Some agents act predominantly at excitatory receptors and some 
predominantly potentiate inhibitory synaptic receptors. In addition, some 
agents are clearly effective at both inhibitory and excitatory postsynaptic 
receptor, so the balance between the inhibition of excitatory synapses and 
the potentiation of inhibitory synapses that may cause general anesthesia 
still needs to be established. It is not known whether these cellular events 
exert their action in relation with specifie structures of the brain. 
1.1.4 The neural substrates of conscious states 
The theories concerning the neural substrates of consciousness tend 
to fall into two classes: (1) neuronal-specificity and (2) process-coherence 
(Cariani 2000). Neuronal-specificity theories postulate specifie neurons 
whose activation supports representation that determine the existence of 
8 
conscious awareness (Crick 1994). The neuronal-specificity embodies the 
notion of structurally localizable seats of consciousness. Process-
coherence theories emphasize particular relational patterns of activity, 
such as adaptive resonances (Gros·sberg 1999), coherent oscillations 
(Llinas et al., 1998), interneural synchronies (Engel and Singer 2001) and 
temporal coherences (John et al., 1997, 2005). Recently Crick and Koch 
(2003) introduced a concept of "framework" for consciousness. This 
framework offers a coherent scheme for explaining the neural correlates of 
(visual) consciousness in terms of competing cellular assemblies. 
Most theories of general anesthesia have focused on basic modes of 
howa neural signalling system might be disrupted. These theories tend to 
fa" into three groups: (1) suppression of neural signal production, (2) 
blockade of neural signal transmission, and (3) disruption of the 
coherence of neural signais themselves or neural processes that interpret 
them. Although many studies are aimed to explore the effects of 
anesthetic agents on synaptic and axonal sites, higher level functional 
consequences are still conceptualized in terms of signal-suppressions or 
transmission blockades. Due to the centrality of the thalamus in its 
connections to the rest of the system, suppression of thalamic activity is 
believed to turn off the entire system. 
9 
1.1.5 Unconsciousness and signal supression 
The suppression of thalamocortical loops and their modulation by 
mid-brain reticular input play a critical rule for the switching of conscious 
state, but we do not know how these circuits are functionally incapacitated. 
It is difficult to use a purely suppressive theory to explain the conditions, 
such as chloralose anesthesia and epileptic seizure, in which increased 
neural discharge rates are associated with loss of conscious awareness. 
With the theory of signal suppression and transmission block, Angel (1993) 
presents the excitatory and inhibitory effects that propofol and other 
general anesthetics can have on thalamic and cortical neurons. These 
findings are consistent with the general reductions in regional cortical 
glucose metabolism (Alkire et al., 1995) and the regional reduction of 
cerebral blood flow in thalamus (Fiset et al., 1999) in their PET study of 
the effects of propofol. Therefore, suppression of activity may be sufficient 
to induce unconsciousness, but the existence of cases in which elevated 
neural discharge is associated with loss of consciousness implies that a 
sufficient level of neural activity by itself may not be sufficient to support 
consciousness. In order to keep consciousness, the neural discharge 
activity must be appropriately organized. 
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1.1.6 Unconsciousness and process-coherence theories and regenerative 
process 
Process-coherence theories emphasize the importance of the proper 
form of neural signais as weil as the functional organization of the system 
that interprets these signais. The coherence message is traditionally 
encoded in the discharge rate profile. Almost ail anesthetic agents affect 
neural discharge rates. Anesthetic agents are also known to alter the 
temporal response characteristics of synapses and axons (Kendig at al., 
1979, Kendig 2002). Many general anesthetics, such as halothane, 
enflurance, and lidocaine, alter axonal membrane threshold recovery 
process, abolishing superexcitable phases (Butterworth et al., 1989). 
These findings suggested that general anesthetics produce 
unconsciousness because they disrupt activity-dependent process, which 
remove the temporal context essential for interpreting nerve impulse 
patterns. If temporal patterning of neural discharge is critical to system 
functioning, the changes in neuronal temporal response might disrupt the 
functional organization of the whole system. General anesthetics might not 
only block the neural signais but also disable the neural computational 
architectures that normal/y interpret those signais. Cariani (2000) 
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suggested that a self-sustaining and self-regenerating set of signaling 
processes might be the underlying mechanism of process-coherence. 
Neural signaling patterns would not be capable of regenerating 
themselves under a certain threshold of activity, therefore, streams of 
consciousness are not sustained. The switching between different sets of 
self-regenerative signais would cause the different states and contents of 
consciousness. 
1 .2 General anesthetic agents 
1.2.1 Class of general anesthetic agents 
General anesthetic agents are classified into two main categories: 
the nonopioid intravenous anesthetics and the inhalation anesthetics. At 
present, the commonly used inhalation anesthetics are nitrous oxide, 
halothane, enflurane, isoflurane, desflurane and sevoflurane. Sevoflurane 
is useful in adults and children for both induction and maintenance of 
anesthesia in inpatient and outpatient surgery. Of ail currently used 
anesthetics, the physical, pharmacodynamic, and pharmacokinetic 
properties of sevoflurane come close st to those of the ideal anesthetic. 
These properties include: inherent stability, low flammability, non-pungent 
odor, lack of irritation to airway passages, low blood/gas solubility allowing 
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rapid induction of and emergence from anesthesia, minimal cardiovascular 
and respiratory side effects, minimal end-organ effects, minimal effect on 
cerebral blood flow, low reactivity with other drugs, and a vapor pressure 
and boiling point that enables delivery using standard vaporization 
techniques (Delgado-Herrera et aL, 2001). The nonopioid intravenous 
anesthetics can be further broken down into barbiturates, 
benzodiazepines and other drugs such as etomidate, ketamine, and 
propofol. 
Among ail nonopioid intravenous anesthetics, propofol is a relatively 
new intravenous anesthetic. Propofol was first synthesized in the early 
1970s and introduced into clinical practice in the late 1980s. Propofol is 
rapidly metabolized and highly lipophilic. Those properties are responsible 
for a pharmacokinetic profile that is more suitable for continuous 
intravenous administration and have led to the development of computer 
driven administration systems that allow targeting of a precise brain 
concentration, depending on the height, the weight, the age and the 
gender of the patient (Shafer et al., 1993). 
1.2.2 Interactions of anesthetic agents with synaptic transmission 
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1.2.2.1 The y-amino. butyric acid receptor type A (GABAA receptor) 
General anesthetics might act by potentiating inhibitory synaptic 
transmission, and the GABAA receptor channel has been considered as a 
potential target. GABA is the most important inhibitory neurotransmitter in 
mammalian brain. Most anesthetics, such as benzodiazepines, 
barbiturates, volatile anesthetics and propofol, are very effective at 
potentiating responses to GABA (Franks et aL, 1994). The degree of 
anesthetic potentiation of GABA receptors depends on their subunit 
compositions and the distribution of subunits throughout the CNS varies 
greatly (Yamakura et aL, 2001). GABA receptor a, b, r subunits are critical 
for potentiation of agonist-induced currents by volatile anesthetics (Mihic 
et aL, 1997). Agonist potentiation by propofol is affected by a point 
mutation of GABAA receptor b subunit (Krasowski et aL, 1998). Although 
uncertainties remain as to the extent to which intact GABAergic synapses 
are potentiated, there are accumulating evidences that point to the GABAA 
receptor channel as a target for most general anesthetics. 
1.2.2.2 The N-methyl-D-aspartate (NMDA) receptor 
Glutamate is the major excitatory neurotransmitter in the mammalian 
brain. Among its receptors, the N-methyl-D-aspartate (NMDA) is the most 
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complex. Its activation leads to a series of intracellular events involving 
several second messenger systems. Ketamine is a non-competitive 
NMOA antagonist, which exerts its anesthetic effects largely by inhibiting 
the NMOA receptors (Franks & Lieb 1994). The anesthesia provided by 
ketamine is characterized by a relatively selective loss of higher cognitive 
functions but it usually preserves arousal. Ali NMDA receptors are strongly 
inhibited by both nitrous oxide (Yamakura and Harris, 2000) and xenon 
(Franks et al. 1998), both of them do not potentiate GABAA receptors. It 
had been speculated by de Sousa et al (2000) that there are at least two 
different routes to anesthesia, volatile anesthetics potentiating GABAergic 
synapses and xenon inhibiting glutamatergic synapses. 
1.2.2.3 The cholinergie system 
The prominent role in memory and consciousness played by the 
CNS cholinergie system is evident from the effects of the muscarinic 
antagonist scopolamine. The techniques, such as in vivo microdialysis and 
chemical neuroanatomy, have expanded our understanding of CNS 
cholinergie pathways. Two cholinergie groups of nuclei are involved in 
CNS projection systems. The brain stem group (Iaterodosal tegmental and 
pedunculopontine tegmental nuclei) projects rostrally along a dorsal 
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pathway to the thalamus and the pontine reticular formation and ventrally 
along a pathway to the basal forebrain. The basal forebrain group (medial 
septum, diagonal band of Broca and nucleus basalis of Meynert) projects 
to the neocortex and the hippocampus as weil as to the amygdaloid 
complex. Afferent input to the cholinergic nuclei comes from various parts 
of the CNS including cortical areas, hippocampus, stria terminalis, preoptic 
area, thalamus, hypothalamus, amygdala, and several brain stem nuclei. 
These input have been characterized as serotonergic, noradrenergic, 
dopaminergic and GABAergic. It is postulated that alteration of central 
cholinergic transmission may play an important role in the mechanism by 
which general anesthetic drugs produce unconsciousness (Durieux ME, 
1996). 
Acetylcholine is the physiologic agonist for both nicotinic and 
muscarinic receptors. These two receptors are completely different entities. 
The nicotinic receptor is a multi-subunit, ligand-gated ion channel or an 
ionotropic receptor and the muscarinic receptor is a single-subunit, G-
protein-coupled receptor or metabotropic receptor. Despite the fact that 
neuronal nicotinic receptors are very sensitive to anesthetic agents, there 
is no evidence as the their role in the CNS mechanism of anesthesia. It 
has been suggested that neural nicotinic receptors do not have a primary 
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role in unconsciousness, but may be involved in the generation of CNS 
side effects of general anesthesia (Downie et al, 2000). 
ln the central nervous system cholinergie transmission is mainly 
mediated by muscarinic receptors. There are five subtypes that are ail 
expressed in the brain of mammals (m1-m5). Muscarinic stimulation, by 
administration of the cholinesterase inhibitor, physostigmine, induces a 
diffuse increase in alertness, making the individual more receptive to 
external and internai inputs, while muscarinic inhibition, in contrast, leads 
to sedation or non-REM sleep, depending on the prior state of the subject 
(Durieux et aL, 1996). Our research group has conducted a series of 
studies on volunteers in which propofol was used to induce 
unconsciousness (Meuret et aL, 2000). These studies demonstrated that 
physostigmine reverses the propofol-induced unconsciousness and 
associated depression of the auditory steady-state response (ASSR) and 
the bispectral index (BIS) in human volunteer. The reversai of the 
unconsciousness and depression of the ASSR and BIS was blocked by 
pretreatment with scopolamine. These findings support the hypothesis that 
the loss of consciousness produced by propofol is mediated, at least in 
part, via interruption of central cholinergie muscarinic transmission. 
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1.2.3 Action of anesthetic agents in the central nervous system 
1.2.3.1 Action of anesthetics to produce immobility 
ln the pa st 15 years, researchers have demonstrated that the spinal 
motor neurons are depressed by inhaled anesthetics (Zentner et aL, 1992, 
Rampil et al., 1996). It was also demonstrated that movement responses 
ta noxious stimulation could occur despite an electroencephalogram made 
essentially isopotential by isoflurance (Rampil and Laster, 1992), after 
removal of cortex and thalamus (Rampil et aL, 1993), and after 
hypothermie transection of the spinal cord (Rampil, 1994). The supporting 
evidence was provided by the findings that neither freezing the cerebral 
hemispheres (Todd et al., 1993) nor causing forebrain ischemia 
(McFarlane et al., 1991) nor using brain-preferential anesthetic procedures 
(Borger and Antognini, 1994) blocked moverment. Ali above evidences 
support the conclusion that immobility may be achieved by action at the 
level of the spinal cord. Several neurotransmitters are plausible 
candidates for mediating immobility. After reviewing the extensive 
literature on the results of interfering with ion channels, Sonner et al. 
(2003) concluded that the actions on multiple receptor systems may 
provide an explanation of how inhaled anesthetics achieve immobility. 
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1.2.3.2 Action of anesthetics to produce amnesia 
For many anesthetics the dose to suppress consciousness 
significantly exceeds that required to prevent memory storage (Chortkorff 
et al., 1995). Memory can be blocked at anesthetic concentrations that do 
not suppress consciousness. Therefore we can believe that the amnestic 
effects of anesthetics are mediated by some processes other than those 
that block consciousness. In a series of PET studies, Veselis et al. (1997 A, 
19978, 2002) demonstrated that the effects of anesthetics on episodic 
memory are related to actions primarily on the dorsolateral prefrontal 
cortex. The anterior cingulate, thalamus, and parietal association areas 
may also be affected. Intracerebral electroencephalographic recording in 
epileptic patients reveal progressive suppression of y activity in the 
hippocampus with increased concentrations of sevoflurane (Uchida et aL, 
2000). This result is supported by subsequent neurophysiologie studies in 
animais that demonstrated septal-hippocampal inactivation and 
suppression of y activity by both volatile and non-volatile anesthetics (Ma 
et aL, 2002). 
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1.2.3.3 Action of anesthetics to suppress consciousness 
Immobilization is likely mediated by effects of the spinal cord while 
amnesia is probably mediated by effects on the dorsolateral prefrontal 
cortex and limbic system. The mechanism of action of anesthetic to 
suppress consciousness is the primary concern of this thesis. We have 
previously introduced the theories concerning the neural substrate of 
consciousness, the theories about how a neural signalling system might 
be disrupted, and the interactions of anesthetic agents with synaptic 
transmission. In the following paragraphs, we will discuss how PET 
functional brain imaging could help us to explore mechanisms of 
unconsciousness induced by general anesthetics. 
1.3 Positron Emission Tomography 
1.3.1 Basic principles 
PET combines the technique of scintigraphy and computerized 
tomography. It utilizes the density of the signal emitted by the labelled 
compound (radiotracer) to reconstruct quantitative images of the tracer's 
concentration. The ability of PET to acquire non-invasive functional 
images makes it a unique tool for studying pharmacokinetic, physiological 
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and biochemical process in vivo in humans. PET provides two kinds of 
information: functional information, such as regional cerebral blood flow, 
metabolism or receptor occupancy during a particular task, and 
anatomical localization (Cherry and Phelps, 1996). So far its principal 
roles include the in vivo measurement of blood flow, metabolism and 
receptor concentrations. This technique is making use of an increasing 
variety of radiolabelled tracers. 
The positron emitting isotopes commonly used for PET tracers are 
mostly 11Carbon, 13Nitrogen, 150xygen, 18Fluorine. The half-lives of 
11Carbon, 13Nitrogen, 150xygen, 18Fluorine are 20.4, 9.96, 2.05, 109.7 
minutes. They are produced by chemical reactions involving one of the 
several common isotopes in a cyclotron. The short half-lives of the 
isotopes reduces the dose of radiation to the subject and allow for repeat 
studies to be performed and also necessitates the presence of an on-site 
cyclotron. The radioisotope then undergoes chemical synthesis producing 
the requiring compound incorporating a positron emitting label. A wide 
variety of molecules such as receptor agonists, water, enzyme substance 
or precursor can be labelled. High initial yields of positron emitters and 
fast subsequent synthesis produce tracers with high specifie activity. The 
specifie activity of a compound is defined to be the ratio of radioactivity to 
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mass of the compound. It should be ensured that the concentrations of the 
unlabelled compound do not interfere pharmacologically with the in vivo 
measurement of the radioligand kinetics (Myers et al., 1992). 
The fundamental mechanism of PET is the emission of a positron 
from an unstable nucleus and the consequent annihilation with a nearby 
electron. This annihilation produces two almost collinear gamma rays of 
511 keV each that can be detected in coincidence on either side of the 
active volume. The localization of the annihilation allows the tracers 
spatio-temporal distribution to be determined. In addition, the detection of 
the two gamma photons as opposed to single photons as in conventional 
nuclear medicine facilitates the determination of absolute tracer 
concentration (Hoffman and Phelps, 1986). This enables functional 
parameters to be accurately derived and increases detection sensitivity. 
1.3.2 Compartmental modeling 
PET provides functional information such as regional blood flow or 
receptor occupancy during a particular task and anatomical localization. 
To derive functional information, it is necessary to perform the appropriate 
tracer kinetic modelling, which allows for the estimation of confound-free 
biological parameters. These particular models require an arterial blood or 
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plasma input function while the number of tissue compartments is dictated 
by the physical, biochemical and pharmacological properties of the system 
under study. Plasma input models in PET often are treated as go Id 
standard (Sokoloff, 1984; Mintun, 1984). The impulse response function is 
a sum of exponentials. The nonlinear least squares methods are used to 
estimate the model parameters. For reversible tissue kinetics, the total 
volume of distribution, VD, is given by the integral of the impulse response 
function. For irreversible tissue kinetics, the irreversible uptake rate 
constant from plasma, KI, is given by the final value of the impulse 
response function (Gunn et aL, 2001). The final value of the impulse 
response function is equal to the limiting slope of a Patlak plot (Patlak et 
al., 1983). 
ln order to avoiding blood sampling, the reference tissue models 
have been developed for neuroreceptor studies (Lammertsma et aL, 1996; 
Gunn et al., 1997; Watabe et al., 2000). Reference tissue models assume 
that there exists a reference tissue essentially devoid of specifie binding 
sites. The number of identifiable compartments in the reference region 
and in the region of interest is dependent on the rate of exchange of the 
tracer between the free, non-specifically bound and specifically bound 
pools of tracer (Gunn et aL, 2001). Parameter estimates may be obtained 
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by the weighted least squares fitting of these models to measured PET 
data. The plasma input models in PET are treated as gold standard and 
reference tissue methods are validated against them. 
1.3.3 Receptor imaging 
Due to the biochemical selectivity of PET, the neuroreceptor can be 
investigated at very low concentration, typically in the nanamolar to the 
picomolar range. Specific radioactive tracers can be designed to bind 
selectively to molecular targets such as enzymes, transporters and 
receptors, as weil as neuromodulators and second messengers. This has 
enabled the evaluation of hypotheses regarding neurotransmitter function 
and regulation that are generated from basic neuroscience studies in 
animais, and the investigation of the neurochemical substrates of 
neurological disorders. A variety of radiolabelled ligands have been 
designed for tracing different signalling systems in the human brain, 
including the dopaminergic, serotonergic, cholinergic, opiate, and 
GABAergic system (Grasby et al., 1996; Kessler, 2003). PET therefore 
provides the unique possibility to identify molecular targets of anesthetics 
and to probe their action on neurochemical process in vivo. 
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1.3.4 Regional Cerepral Slood Flow and cerebral metabolic rate for 
glucose 
Regional cerebral blood flow (rCBF) and cerebral metabolic rate for 
glucose (CMRGlu) are two useful indices of regional brain function. In 
cognitive neuroscience, PET study is often used to map changes in rCBF 
and CMRGlu caused by well-defined stimuli or tasks. These studies are 
usually called activation studies. PET studies of anesthesia action in the 
human brain are often based on comparing brain physiological variables 
measured under different states of anesthesia. Regional changes in CBF 
and CMRGlu are assumed to reflect changes in regional neural activity 
and may provide neuroanatomical evidence for behavioural responses 
associated with unconsciousness induced by general anesthetics. 
The idea that blood flow within a specific region of the brain is closely 
related to function was first presented by Roy and Sherrington in 1890 
(Roy et aL, 1890). The theoretical basis for regional rCBF measurements 
with PET is the animal research by Kety (1951, 1960), which allows 
assessment of rCBF in laboratory. There is no doubt that activation of 
brain areas is associated with an increase in rCBF (Friedland et al., 1979) 
although the exact relationship between those changes and the way they 
are mediated are not fully understood. In human studies, the tracer of 
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choice of rCBF measurement is 150-labeled water (H2150)(Herscovitch, 
2001). This molecule can diffuse freely across the blood-brain barrier. Due 
to its short half-life (2 min) the tracer allows the performance of repeated 
measurements in a single study session. After injection of a single dose of 
H2150 PET images are immediately acquired to obtain the brain time 
activities and to calculate maps of rCBF. 
The regional cerebral metabolic rate of glucose utilization (rCMRglu) 
can be measured with a PET scanner and [18F]fluorodeoxyglucose 
(18FDG). As a glucose, this tracer is taken up by brain neurones 
depending on their functional state. It is phosphorylated in the brain tissue 
by hexokinase to FDG-6-phosphate. Unlike glucose, FDG-6-phosphate 
becomes intracellularly trapped for at least 45 min without being further 
metabolized. Uptake of FDG and metabolic trapping of FDG-6-phosphate 
is nearly complete about 30 min after injection of the tracer. The amount of 
radioactivity in each region of the brain is related to the glucose uptake 
and the glucose metabolism in this region. However, this technique has 
obvious limitations. Due to the long half-life (110 min) and the long uptake 
period, repeated scans are difficult to perform, many drug studies have 
been performed using rCBF rather than CMRGlu as an index of local 
cerebral activity (Herscovitch, 2001). 
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1.3.5 Role of PET studies in the research of the mechanism of 
unconsciousness 
Alkire et al. (1997, 1999, 2000) have examined the effects of propofol 
and of two inhalation general anesthetics, isoflurance and halothane, on 
neuronal activity in humans with the PET-FDG technique. In these studies 
the anesthetics were incrementally titrated to the point of 
unresponsiveness and brain glucose metabolism was investigated during 
steady-state conditions. At the same clinical end point, similar results in 
global brain glucose metabolism were obtained for the three agents. 
Halothane decreased global glucose metabolism by 40%, isoflurane by 
46%, and propofol by 55%. This general decrease in metabolic activity is 
believed to reflect the reduced synaptic activity across the brain during 
anesthesia. They also revealed the differences in regional metabolic 
reduction caused by the volatile agents. They found that both isoflurane 
and halothane caused a specific relative reduction of regional cerebral 
glucose metabolism primarily in the thalamus and also in the midbrain 
reticular formation, basal forebrain, cerebellum, and occipital cortex (Alkire 
et aL, 2000). These findings reflect the importance of the thalamus as a 
target in inhibition of the flow of information to the cortex. 
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The results of recent H2150 PET studies in our research group further 
support the hypothesis that specifie neural networks contribute to the 
unconsciousness induced by anesthetics (Bonhomme et al., 2001; Fiset et 
al., 1999). Fiset and co-workers (1999) investigated rCBF during graded 
changes of propofol anesthesia. They found a 20.2% overall decrease in 
absolute CBF, indicating an overall decrease in cortical neural activity. 
They also found a strong correlation between the level of consciousness 
and the reduction in CBF in the thalamus, basal forebrain, and occipital 
and parietal regions. In addition, a significant covariation between the 
thalamic and midbrain blood flow changes was observed, suggesting a 
close relationship between these structures. These findings have been 
confirmed by another study of our research group (Bonhomme et al., 
2001). In this study, a stimulus-induced study design was chosen. 
Changes in rCBF were measured in order to determine whether different 
levels of propofol anesthesia would affect subcortical and cortical 
processing of vibrotactile stimuli in a different way. This study showed a 
dose-dependent impairment of the processing of vibrotactile stimuli in a 
different way. Suppression of rCBF response in thalamus was found only 
when volunteers have lost consciousness. This finding provides further 
evidence for the importance of thalamus in mediating drug-induced 
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unconsciousness. Specifie changes in rCBF were also reported for 
midazolam. Veselis et al. (1997B) found that the largest decrease of rCBF 
was in thalamus during deep midazolam sedation. Other PET studies of 
benzodiazepines also demonstrated large decrease in regional neural 
activity in the thalamus after lorazepam (Volkow et aL, 1997) and 
midazolam administration. 
Different radioligands have been used to examine different or same 
receptors binding in PET studies. Accuracy of receptor binding 
measurement depends on the kinetic praperty of the radioligands. To 
quantify muscarinic receptor binding, different PET studies have employed 
different radiotracers, including [11C]scopolamine (Frey et aL, 1992), 
[11C]tropanyl benzilate (koeppe et aL, 1994), [11C]benztrapine (Dewy et aL, 
1990, 1993), and [1251]3-qyunuclidinyl-4-iodobenzilate (Sawada et aL, 
1990). But these agents share relatively slow dissociation rates from the 
muscarinic receptor, which may limit the precision of their uses for 
receptor binding estimates. Additionally, compartmental kinetic analysis is 
hindered when the rate of ligand binding is rapid relative to the rate of its 
transport fram blood to tissue, because tissue activity levels become 
delivery limited and receptor estimates become prone to bias from effects 
of altered blood flow. A novel, radiolabelled, muscarinic receptor 
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antagonist, [11C]N-methyl-4-piperidyl benzylate (NMPB), was developed 
by Mulholland et al. (1995), and has more favorable kinetic properties. 
NMPB has higher dissociation rates than many of the prior radioligands. 
Tracer kinetic modeling with NMPB has been verify and validated in recent 
studies published by Zubieta et al. (1998, 2001). 
1.4 Study Design 
Chapter 2 describes the first study presented in this thesis: PET 
quantification of muscarinic cholinergie receptors with [N-11 C-methyl-
benztropine and application to studies of propofol-induced 
unconsciousness in healthy human volunteers. This study allows us to 
understand the effect of propofol on central muscarinic receptor availability 
during general anesthesia. It introduces the kinetic analysis methods for 
estimation of the receptor availability of the muscarinic receptor using 
dynamic positron emission tomography (PET) studies with [N-11C-methyl]-
benztropine. Chapter 3 presents the second study of the present thesis: a 
PET investigation of the brain function changes specifically linked to the 
difference in level of consciousness. In this investigation, we used 
physostigmine (an anticholinestherase) to restore consciousness induced 
by propofol. Chapter 4 is the general discussion about a complete 
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neurophysiological theory of the action of anesthetics to suppress 
consciousness and a theory of consciousness restored by physostigmine. 
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Chapter 2 PET Quantification of Muscarinic Cholinergie 
Receptors with [N-11C-methyl-benztropine and Application to 
Studies of Propofol~induced Unconsciousness in Healthy 
Human Volunteers 
Xie, G., Gunn R.N., Dagher A., Daloze T., Plourde G., Backman S., Fiset 
P. (2004). PET Quantification of Muscarinic Cholinergie Receptors with [N-
11 C-methyl-benztropine and application to studies of Propofol-induced 
Unconsciousness in Healthy Human Volunteers. Synapse 51: 91-101, 
2004. 
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2.1 Abstract 
This work evaluated kinetic analysis methods for estimation of the 
receptor availability of the muscarinic receptor using dynamic positron 
emission tomography (PET) studies with [N-11C-methyl]-benztropine. The 
study also investigated the effect of propofol on central muscarinic 
receptor availability during general anesthesia. Six volunteers were 
scanned three times, once for baseline whilst awake, once during 
unconsciousness, and once after recovery to conscious level. An 
irreversible two-tissue compartment model was used to estimate the [N-
11 C-methyl]-benztropine specifie binding rate constant k3, a measure of 
muscarinic receptor availability. Two different estimation methods were 
used: (1) optimization with positivity constraints on ail the parameters; (2) 
optimization with additional constraints determined from a one-tissue 
compartment fit to the cerebellum. In regions with low to middle 
muscarinic receptor density, the k3 values from method (2) had lower 
standard errors than that for method (1) and gave a higher correlation with 
the density of muscarinic receptors measured by in vitro studies (r2 of 
0.98 for method 2 and r2 of 0.72 for method 1). But the k3 values 
determined by method 2 had higher errors for regions with high muscarinic 
receptor density as compared to method 1. For both methods, the mean 
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k3 values during unconsciousness were generally lower than those during 
awake for most regions evaluated. Given the higher degree of correlation 
with in vitro data, the method with additional constraints derived from the 
cerebellum (method 2) was deemed superior for regions with low to 
middle muscarinic receptor density. The finding may also suggest 
propofol-related reductions in muscarinic receptor availability. 
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2.2 Introduction 
The present study was designed to determine the changes in muscarinic 
receptor occupancy of the brain during general anesthesia with propofol 
using Positron Emission Tomography. PET has been used to study the 
distribution and occupancy of muscarinic receptors in the human brain, 
using [11C]scopolamine, [11C]N-emthy-4-piperidyl benzilate (NMPS), 3-
quinuclidinyl-4-iodobenzilate (ONS), and [N-11C-methyl]-benztropine. We 
have used [N-11C-methyl]-benztropine, a non-selective muscarinic 
receptor antagonist, and propose a method of analysis that attempts to 
address some of the challenges in quantifying receptor parameters with 
an irreversibly bound radiotracer. 
The use of PET with ligand displacement techniques for the study of 
anesthetic mechanism is supported by the fact that some properties of 
anesthetic drugs, including loss of consciousness and antinociception, 
have been shown to be related to their specifie effects on ligand-gated ion 
channels, pre- and postsynaptic receptors and second messenger 
systems (Franks NP et al, 1994; Yamakura T et aL, 2001). However, the 
mechanism underlying loss of consciousness is poorly understood. Many 
neurotransmitter systems are affected during pharmacological sedation, 
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including GABA (Mihic SJ et aL, 1997; Gyulai FE et aL, 2001; Alkire MT et 
aL, 2001), glutamate (Flohr H et aL, 1998, Cheng G et aL, 2000) and 
acetylcholine (ACh) (Tassonyi E et aL, 2002). 
ACh has been a target of investigation in sleep states and anesthetic 
induced alteration of consciousness. It has been postulated that the level 
of acetylcholine in the medial pontine reticular formation plays an 
important role in the generation of REM sleep states. Furthermore, 
microdialysis studies performed in animais have shown that following the 
administration of drugs like morphine and halothane, ACh levels in the 
medial pontine reticular formation were significantly decreased compared 
to the awake state. Recent rat studies using in vivo microdialysis have 
also demonstrated that propofol has dose-dependent inhibitory effects on 
acetylcholine release in the frontal cortex and hippocampus (Kikuchi T et 
aL, 1998; Wang Y et aL, 2000). Furthermore, Pain L et al. (2000) showed 
that a central cholinergie depletion attenuates the sedative effect of 
propofol in the rat brain. Their results suggest that basal forebrain 
cholinergie neurons might mediate part of sedative /hypnotic effects of 
propofol. 
ACh is the physiologie agonist for both nicotinic and muscarinic 
receptors. The nicotinic receptor is a multi-subunit, ligand-gated ion 
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channel or an ionotr.opic receptor and the muscarinic receptor is a single-
subunit, G-protein-coupled receptor or metabotropic receptor. Despite the 
fact that neuronal nicotinic receptors are very sensitive to anesthetic 
agents, it has been suggested that nicotinic receptors in the brain do not 
have a primary role in unconsciousness, but may be involved in the 
generation of CNS side effects of general anesthesia (Downie et al, 2000). 
On the other hand, it is believed that muscarinic transmission is one 
of several pathways that play a significant role in the process of sedation 
(Durieux ME et al., 1996). In the CNS cholinergie transmission is mainly 
mediated by muscarinic receptors. There are five subtypes that are ail 
expressed in the brain of mammals (m1-m5). The prominent effect on 
memory and consciousness played by the CNS cholinergie system is 
evident from the effects of the muscarinic antagonist scopolamine 
(Durieux ME, 1996). In a series of studies do ne on human volunteer, our 
group has shown that physostigmine reverses the propofol-induced 
unconsciousness in human volunteers. The reversai of the 
unconsciousness was blocked by pretreatment with scopolamine. Our 
findings support the hypothesis that the loss of consciousness produced 
by propofol is mediated at least in part via interruption of central 
cholinergie muscarinic transmission (Meuret P et al., 2000). The combined 
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evidence that during. anesthesia, ACh levels are deereased in the pontine 
reticular formation as weil as in the projection systems in the cortex, and 
that scopolamine, possibly via a muscarinic mechanism, mediates 
conscious levels during anesthesia has led us to study in humans the 
changes in muscarinic receptor occupancy during anesthesia. 
Dewey et al have, in a series of studies, used [N-11C-methyl]-
benztropine to map muscarinic receptor density and determine the 
modulatory effect of various neurotransmitters on muscarinic transmission. 
They found that the greatest incorporation quotient (10) of radioaetivity 
was the corpus striatum and reported smaller values in the frontal, parietal 
and temporal cortices. The 10 closely corresponded to the distribution of 
muscarinic receptors as demonstrated by autoradiographie studies of 
postmortem human brain (Dewey SL et al., 1990). Additionally, using the 
distribution volume (DV) measured by Logan plot, they demonstrated that 
drugs acting upon either GABAergic or serotonergic neurons produced 
profound regional changes in acetylcholine release (Dewey SL et aL, 
1993). In this study, we developed an approach to estimate the receptor 
availability using compartmental modeling. Different compartmental 
models were initially fitted to the data in order to identify an appropriate 
model. 
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The aim of thi$ study was to determine an appropriate method to 
estimate CNS muscarinic receptor availability using PET and [N_11C-
methyl]-benztropine. Using the identified method, we tested the 
hypothesis that the loss of consciousness induced by propofol is mediated 
at least in part by the reduction of central muscarinic transmission by 
demonstrating the changes in muscarinic receptor availability during 
unconsciousness induced by propofol. 
2.3 Methods 
2.3.1 Subjects 
Six healthy volunteers aged 21-35 years (mean 25.8 ± 7.2, 2 men, 4 
women) were recruited via local newspaper advertisements and studied 
after appropriate medical evaluation. The studies were approved by the 
Research Ethics Committee of the Montreal Neurological Institute and 
Hospital and informed written consent was obtained. Women were tested 
for pregnancy no more than 1 week before the experiment and were 
requested to use an appropriate contraceptive method. 
2.3.2 Monitoring and data acquisition 
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After comfortable installation on the PET scanner bed, anesthesia 
monitoring devices (EKG, pulse oxymeter and respiratory impedance) 
were applied. EEG electrodes were placed at FP and FP referred to A 1 for 
measurement of the bispectral index (BIS). BIS is a quantitative EEG 
variable used clinically for guiding the administration of anesthetic agents. 
An intravenous catheter was placed in the right forearm for drug infusion. 
Another catheter was inserted in the left radial artery for procurement of 
blood samples for determination of propofol plasma levels (Plummer et al., 
1987) and radiotracer activity via subsequent counting in aNal well-
counter. Oxygen was administered at a rate of 3L/min through nasal 
prongs. Subjects are blindfolded, and ambient noise is kept to a minimum. 
2.3.3 Drug administration control 
Subjects fasted for at least 8h prior to the study. Propofol was given 
using a computer controlled infusion pump (CCIP) and the infusion 
program STANPUMP. That program uses pre-determined population 
pharmacokinetics, the volunteer's pertinent covariates, and a multi-
exponential infusion algorithm to quickly reach and maintain a target 
plasma concentration (Tackley RM et aL, 1989). Propofol plasma 
concentrations of 2.0, 3.0 or 4.0 ug/ml were targeted depending on the 
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minimal plasma concentration associated with loss of consciousness 
which was defined as the loss of response to verbal commands (" Move 
your toes, raise your thumb." ). These concentrations were compatible 
with safe, spontaneous breathing. Once unconsciousness was reached, 
PET scanning was delayed by 10 minutes to allow for blood-brain 
equilibration of propofol concentrations (Dutta S et aL, 1998). 
2.3.4 Scanning procedure 
Three separate dynamic PET brain scans (CTI/Siemens HR + PET 
tomograph, 32-ring, 63-slices) were obtained in each subject: baseline 
(awake prior to propofol infusion), unconscious (during propofol infusion), 
and regained consciousness (following cessation of propofol infusion, 
subject fully awake). Each scan was performed for a period of 60 minutes 
following an intravenous injection of [N-11C-methl]-benztropine (13 mCi). 
To measure the plasma input function of [N-11C-methl]-benztropine to the 
brain, arterial blood samples were obtained every 30sec from 15 sec to 
120 sec, and then subsequently at 3, 4, 6, 8, 11, 15, 20, 30, 40, 50, and 
60 min after tracer injection. Blood samples were centrifuged to separate 
plasma, weighted, and their plasma radioactivity was determined for 
estimation of the input function that is illustrated in Figure 2-1 A. Arterial 
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blood samples for propofol assay were taken just before the injection of 
benztropine, and twice post-injection (30 min & 60 min). Each subject 
received an MRI scan on another day to provide adjunct structural data for 
region of interest definition. 
2.3.5 PET data analysis 
A summed radioactivity image was generated from each scan and 
co-registered to the individual's MRI using automated algorithms (Evans et 
aL, 1992). Regions of interest (ROis) were drawn on each subject's MRI 
on the anterior cingulate cortex (ace), caudate nucleus (cau), cerebellum 
(cbl), frontal cortex (frc), globus pallidus (glp), occipital cortex (occ), orbito-
frontal cortex (ofc), pons (pon), putamen (put), thalamus (tha), temporal 
lateral cortex (tic), and temporal medial cortex. Left and right ROis were 
combined for the data analysis. The time-activity curves (TAC) for each 
ROI were extracted from the dynamic PET data (Figure 2-1 B) and used 
for the regional quantification of the binding of [N-11C-methl]-benztropine. 
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Figure 2-1: Plasma and tissue time-activity curves 
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2.3.6 Arterial input f~nction 
The discrete plasma radioactivity measurements were interpolated 
with a step function (having a value of 1 between the time of injection and 
peak plasma radioactivity and 0 elsewhere) convolved with a sum of 
exponentials (the fit was obtained using a non-negative least squares fit of 
a set of basis functions). As individualized metabolite data was not 
available a population based metabolite correction was applied according 
to the published data of Dewey et al. (1990). Dewey et al determined the 
percent of unchanged [N_11 C-methl]-benztropine in human and baboon 
plasma. They found that the metabolism of [N-11C-methl]-benztropine in 
human plasma is very slow in sharp contrast to that in baboons. An 
exponential function was fitted to their human data to allow for an 
approximate correction of the plasma data. The equation for the parent 
radiotracer fraction in plasma was aexp(-~ t), where a=0.98, ~ =0.0056 
min-1, and t is the time after injection. This allowed for an estimate of the 
parent plasma radioactivity time course based on population metabolite 
data. 
2.3.7 Compartment modeling 
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Ta determine an appropriate model for benztropine kinetics, we 
evaluated three compartment models including a one-tissue 
compartmental model (2 parameters), and two-tissue compartmental 
models with (3 parameters - irreversible binding), and (4 parameters -
reversible binding) (Figure 2-2; for more detail see Appendix C of Gunn et 
al., 2001). Madel parameters and the residual sum of squares (RSSQ) 
were estimated for each of the 13 brain regions for the three models by 
nonlinear least-squares fitting. Weighted least squares fitting were 
performed with weights determined from the whole brain data and 
calculated as (frame duration/whole brain TAC). An F test was used ta 
assess the reduction in the sum of squares for more highly parameterized 
models and thus impart information on the most appropriate model. With 
the 3 parameter model, 181 out of 234 data sets were fitted significantly 
better than the 2 parameter modal. But with 4 parameter model, only 42 
out 234 data sets were fitted significantly better than 3 parameter model. 
Thus, the irreversible two-tissue compartmental model with 3 parameters 
was chosen as the most appropriate model for these data. For cerebellum 
alone, with the 3 parameter model, 13 out of 18 data sets were fitted 
significantly better than the 2 parameter model. With 4 parameter model, 8 
out 18 data sets were fitted significantly better than 3 parameter model. 
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Figure 2-2: Compartmental models 
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Two-tissue irreversible compartmental (3k) model. The net irreversible 
uptake rate constant fram plasma is given by, 
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Bottom: Two-tissue reversible compartmental (4k) model. The distribution 
of receptor-binding ligands indudes an intravascular compartment (Cp) 
and three tissue tracer compartments representing free tracer (CF), 
nonspecifically bound tracer (CNs), and specifically bound tracer (Cs). 
CF+NS+S is the simplification of the model combines ail three tissues pools 
into a single compartment. CF+Ns is the simplification of the model, which 
combines two tissue pools into a single compartment. 
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For the cerebellum the reversible two-tissue compartmental model with 4 
parameters was selected. 
Accurate estimation of individual parameter values from an 
irreversible two-tissue compartment model is usually not possible because 
of the high degree of correlation between the parameters k2 and k3. 
Furthermore, there is also a problem when using a macro parameter such 
as the net irreversible uptake rate constant from plasma (KI) as this 
parameter is not inde pendent of blood flow. In order to improve the 
accuracy of the individual rate constant estimation process the inclusion of 
additional constraints was investigated; Method 1 - based on basic 
biologie properties of the model ail parameters were constrained to be 
non-negative within the non-linear least squares fitting process. Method 2 
- The K1/k2 ratio in tissue regions was constrained to the volume of 
distribution (VD) values obtained from a two tissue compartment model fit 
to the cerebellum data, leaving only two parameters to be estimated by 
non-linear least squares. Koeppe et al. have explored the possibility of 
constraining the ratio of the transport parameters (K1/k2) as this ratio can 
be relatively constant across the brain for many PET tracers studied 
(Koeppe et al., 1999). To evaluate kinetic analysis alternatives for 
estimation of relative acetylcholinesterase activity using dynamic PET 
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studies of irreversible tracer [11C] PMP, they constrained the K1/k2 ratio (= 
4.0) to the mean estimate across cortical regions of ail subjects fram the 
unconstrained fits. They demonstrated that constrained methods yielded 
lower Coefficient of Variation and were superior in regions with moderate 
to high AChE activity. 
Lin et al. (1986) demonstrated that the density of muscarinic receptor 
in cerebellum is very low compared with cortex and striatum. Therefore 
the cerebellum was the most apprapriate choice for the region in which to 
determine the free+non-specific binding volume of distribution. We 
determined the K1/k2 ratio for the cerebellum of each scan of each subject 
and then fixed this to a constant value for ail subsequent irreversible 
compartmental model fits for that scan of that subject. 
2.3.8 Statistical analysis 
Changes in the parameter estimates k3, K1 and KI were assessed 
using a two-way within subject analysis of variance (ANOVA), the first 
factor being the experimental periods (awake, unconsciousness, recovery), 
and the second factor being the brain regions (the brain region measured). 
Tukey's HSD tests were used for the post-hoc comparisons. Due to the 
variance of K3 during unconsciousness is lower than those during awake 
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and recovery condition, which indicates the K3 value is not normal 
distributed, we also tested the main effect of experimental condition using 
the Freedman's test. Then we used Wilcoxon test for post-hoc 
comparisons. We analyzed the variability of the heart rate (HR), the mean 
arterial pressure (MAP), and BIS across conditions using a one-factor 
within-subject ANOVA and Tukey's HSD for post-hoc comparisons. 
Values are expressed as the mean ± 1 SD unless specified and a p<0.05 
was considered significant. 
2.4 Results 
2.4.1 Monitoring 
Ali (six) volunteers enrolled completed the study. The BIS, MAP, and 
HR were measured at 0' , 10' ,20' , 30' ,40' , 50' ,and 60' of 
each scan. The BIS during unconsciousness was significantly lower than 
those during awake and recovery (p< 0.01). The MAP during 
unconsciousness was significantly lower than those during awake and 
recovery (p < 0.01). There were no significant differences among three 
experimental periods concerning HR (p > 0.05) (Table 2-1). 
2.4.2 PET data analysis 
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Table 2-1. BIS - Bispectral index, MAP and HR data 
Scan1 Scan2 Scan3 
BIS 93.5 ± 3.5 36.8 ± 4.9* 93.9 ± 3.0 
MAP (mmHg) 91.9 ± 3.8 69.8 ± 5.9* 91.5 ± 4.0 
HR (beats.min-1) 69.4 ± 17.7 69.5 ± 5.9 60.0±11.2 
Values are mean ± SE. 
* P<0.01 compared with Scan1 and Scan3. 
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2.4.2.1 Method 1 - Parameter positivity constraints 
Mean K1 and KI were generally higher during unconsciousness and 
recovery than during awake. A two-way within-subject ANOVA on K1 and 
KI revealed no significant main effect of consciousness states (K1: p = 0.60, 
KI: p = 0.79), a significant main effect of brain regions (p < 0.0001) for KI, 
no significant main effect of brain regions (p =0.21) for K1 (Figure 2-3). 
Figure 2-4 shows the k3 values during awake, unconsciousness, and 
recovery in ail regions. Mean k3 values during unconsciousness were 
generally lower than those during awake for most regions evaluated. A 
two-way within-subject ANOVA on k3 revealed no significant main effect of 
the experimental periods (p = 0.087) and a significant main effect of brain 
regions (p < 0.0001). Using the Friedman's test, we find the significant 
main effect of the experimental periods in cerebellum (p=0.03) and parietal 
cortex (p=0.01). Post-hoc pairwise comparisons using Wilcoxon test 
revealed k3 during unconsciousness wassignificantly lower than that 
during wake condition in parietal cortex (p=0.03) and k3 during recovery 
was significantly lower than that during wake condition in cerebellum 
(p=0.03). Figure 2-5 compares the k3 values measured in our PET study 
with the known muscarinic receptor distribution measured with [3H]-QNB in 
human post mortem material (Lin et al., 1986). We found that 
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Figure 2-3: The KI and K1 values estimated with Method 1 
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Figure 2-4: The k3 values estimated with Method 1 
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Figure 2-5: Comparison of k3 values fram Method 1 with the muscarinic 
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54 
the k3 measured in vivo with our PET study is correlated with density of 
muscarinic receptors measured in vitro study with an r2 of 0.72. 
2.4.2.2 Method 2 - Constraining free+nonspecific VD with values from the 
cerebellum 
Mean K1 and K, were also generally higher during unconsciousness 
and recovery than during awake. A two-way within-subject ANOVA on K1 
and K, revealed no significant main effect of consciousness states (K1: p = 
0.089, K,: p = 0.78), but did reveal a significant main effect of brain regions 
(K( p < 0.001, K,: p < 0.001) (Figure 2-6). Figure 2-7 shows the k3 values 
during awake, unconsciousness, and recovery in ail regions evaluated. 
Mean k3 values during unconsciousness were generally lower than those 
during awake for most regions evaluated, and mean k3 values during 
recovery were also generally lower than those during awake, and were 
generally higher than those during unconsciousness (recovery toward the 
awake level) for most regions. A two-way within-subject ANOVA on k3 
revealed no significant main effect of the experimental periods (p = 
0.1568). Using the Friedman's test, we find the significant main effect of 
the experimental periods in frontal cortex (p=0.03), orbital-frontal cortex 
(p=0.03) and temporal medial cortex (P=0.03). Post-hoc pairwise 
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Figure 2-6. The KI and K1 values estimated with Method 2 
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Figure 2-7. The K3 values estimated with Method 2 
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comparisons using Wilcoxon test revealed k3 during unconsciousness was 
significantly lower than that during wake condition in frontal cortex 
(p=0.03), orbital-frontal cortex (p=0.03) and k3 during unconsciousness 
was significantly lower than that during recovery condition in temporal 
medial cortex (p=0.03). Figure 2-8 compares the k3 values measured in 
our PET study with the known muscarinic receptor distribution measured 
with [3H]-QNB in human material (Lin et aL, 1986). The k3 estimated in 
vivo with our PET study is closely correlated with the density of muscarinic 
receptors measured in vitro study with an r2 of 0.98. 
2.5 Discussion 
The main goal of this study was to examine the feasibility of using [N-
11 C-methyl]-benztropine for the quantification of muscarinic receptor 
binding during wakefulness, propofol-induced unconsciousness, and 
recovery in health volunteers. In this study, an irreversible two-tissue 
compartment model was determined as the most appropriate model for 
[N-11C-methyl]-benztropine. 
Irreversibly bound radioligands are a challenge for quantification 
methods. Whilst, the net irreversible uptake rate constant from plasma can 
"7,-0. 
= 
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Figure 2-8: Comparison of k3 values fram Method 2 with the muscarinic 
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be estimated accurately, the parameter itself is confounded by blood flow. 
Estimation of the individual rate constant k3, which measures the receptor 
availability, is compromised by numerical unidentifiability issues related to 
the parameters high degree of correlation with k2. The most successful 
approaches to this problem have involved the addition of constraints to the 
estimation problem. For example, to estimate the relative 
acetylcholinesterase (AchE) activity using an irreversible tracer, N-
[11C]Methylpiperidin-4-yl propionate ([11C]PMP), Koeppe et al.(1999) 
compared an unconstrained nonlinear least-squares fit estimating the 
hydrolysis rate constant k3 with the methods of constraining the fit by fixing 
the volume of distribution. They found that the constrained methods are 
required to yield meaningful estimates and are superior to the 
unconstrained methods. Lin et al. demonstrated that the density of 
muscarinic receptor in cerebellum is very low comparing with cortex and 
striatum (Lin et aL, 1986). Thus, in this study, the free and non-specifically 
bound volume of distribution was approximated from the cerebellum as 
this region has a low amount of specifie binding. 
Comparison of methods 1 and 2 revealed that adding constraints 
derived from the cerebellum provided a better correlation with in vitro 
measures of the muscarinic receptor density (Method 2 : r2 = 0.98, Figure 
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2-8 and Method 1 r2 = 0.72, Figure 2-5). Both sets of results are consistent 
with the specificity of the [N-11C-methyl]-benztropine for the muscarinic 
sites. The mean coefficients of variation (mCOV) of k3 values during three 
PET scans with two different constraints are shown in the Figure 2-9. For 
the brain regions with low (cbl, pon) and high (cau, put) muscarinic 
receptor density, the k3 values estimated by constraining K1/k2 have 
higher mCOV values comparing with the k3 estimated with a positivity 
constraint. For most brain regions with middling muscarinic receptor 
density, the k3 values estimated with a constraint on K1/k2 have lower 
mCOV values as compared with the k3 estimated with positivity constraint. 
It has been weil documented that a workable irreversible PET 
radioligand should have not too large a k3 and a reasonable match 
between the rate of trapping (k3) and the rate of BBB transport (k2) 
(Koeppe 1996, Frey et al, 1992). If k3/k2 is too low, the fraction of tracer 
trapped is not large enough to give a good signal. If k3/k2 is too high the 
trapping of radiotracer is limited by delivery to the tissue. Whereas K1 
continues to be estimated precisely, the estimates of k2 and k3 become 
extremely variable, yet remain highly correlated. The optimal range for k3 
and k2 tends to be when the rate constants are of similar magnitudes 
61 
Figure 2-9: Mean Coefficients of Variation of k3 values with two different 
model constraints 
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(Koeppe et aL, 1996, 1999). For most regions evaluated in this study 
(excluding areas of Caudate Nucleus and Putamen), the values of k3/k2 
during awake tended to be too large for optimal estimation, with mean 
k3/k2 ratios ranging from about 0.3-9.4. The value of k3/k2 during 
unconsciousness and recovery came closer to the optimal range, with 
mean ranges from 0.1-3.3 and 0.1-4.2. This likely explains the reason for 
lower COVs of k3 estimates during unconsciousness and recovery than 
during awake (Figure 2-10). The estimated k3/k2 ratios of subject 1 in 
Putamen and subject 2 in Caudate Nucleus and Putamen are very high 
(>500). Therefore, in the areas of high receptor density (Caudate Nucleus 
and Putamen), accu rate estimation of k3 is not possible (Table 2-2). In 
these regions, [N_11 C-methy)-benztropine suffers the same problem with 
that of other irreversible tracers, with the irreversible rate of trapping being 
too rapid rather than too slow. 
ln a previous human PET study with [N-11C-methl]-benztropine, 
Dewey et al (1990) determined the incorporation quotient (10), which is 
equivalent to the KI determined by compartmental modeling in this article. 
Their mean 10 value (0.099 in frontal cortex) is comparable to our mean KI 
values (0.12 for Method 1 and 0.094 for Method 2 in frontal cortex whilst 
awake). 
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Figure 2-10: Coefficient of variation of k3 estimates (Method 2) in the 
regions with median muscarinic receptor availability 
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Table 2-2. Estimated k3 (min-1)(mean (80)) in the regions of caudate 
nucleus (cau) and putamen (put) 
Experiment stages Awake Unconsciousness Recovery 
Brain regions cau Put cau put cau put 
Method 1 
Positivity constraints 0.14 0.28 0.09 0.078 0.14 0.12 
on parameters 
(0.10) (0.30) (0.055) (0.05) (0.13) (0.11 ) 
Method 2 
K1/k2 ratio constrained 0.22 2.76 0.072 0.078 4.08 2.04 
to Vo of the (0.16) (6.6) (0.055) (0.018) (9.6) (4.74) cerebellum 
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Despite the high variance associated with estimates of k3, our results 
demonstrate that k3 values during unconsciousness were generally lower 
than those during awake for most regions evaluated. Furthermore, we 
found that the k3 measured in vivo with our PET study is closely correlated 
with the density of muscarinic receptors measured in vitro (r2 = 0.98), 
which provides evidence for the specificity of [N_11 C-methyl]-benztropine 
for the muscarinic sites. This result may suggest a propofol-related 
reduction in muscarinic receptor binding. The related reduction in 
muscarinic receptor binding theoretically could be caused by the increase 
of endogenous ACh, although this would contradict the clinical effect of 
propofol. A significant increase of endogenous ACh in CNS will produce 
alertness and REM sleep (Durieux ME et al., 1996). Furthermore, in 
animal studies using vivo microdialysis it has been demonstrated that 
propofol has dose-dependent inhibitory effects on acetylcholine release in 
the frontal cortex and hippocampus (Kikuchi et al., 1998; Wang et al., 
2000). 
Three possible mechanisms for the effects suggested by the present 
study are discussed. First, muscarinic receptors may be expressed in 
several conformations, which can be distinguished on the basis of agonist 
binding affinity (Birdsall et al., 1978). It is possible that propofol decreases 
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the affinity of muscÇlrinic receptor to ligand and causes a conversion of 
muscarinic receptors from high affinity states to conformational states 
characterized by lower affinity. This notion is consistent with the finding 
from later experiments (Dennison et al., 1987) where [3H] Oxotremorine-M 
was used as a probe to investigate the effects of halothane on high affinity 
agonist binding to muscarinic receptors in the brainstem of the rat. Their 
results suggested that halothane converts both G protein-coupled and 
uncoupled muscarinic receptors to states of lower agonist affinity. 
However, benztropine's Kd is 4-7 nmol/L for the muscarinic M1 and M2 
site (Snyder et al., 1977). Therefore, it may also bind significantly to 
receptors in low affinity states. Second, it is possible that propofol directly 
binds to the muscarinic receptors. Yamamoto et al. (1999) measured the 
affinity of propofol to muscarinic receptors of myocytes with a competitive 
binding assay using [3H] ONS. Their results supported the idea that 
propofol had an affinity for muscarinic receptors. Third, unfortunately it 
was not possible to guarantee the accu rate correction of the plasma data 
for metabolite contributions as no individual metabolite data was available. 
Thus, a change in metabolism of the radioligand induced by propofol could 
account for any changes in the measure of receptor availability. 
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Meuret P et al (2000) demonstrated that physostigmine reverses 
propofol-induced unconsciousness and the associated depression of 
ASSR and BIS in human volunteer. The reversai of the unconsciousness 
and depression of the ASSR and BIS was blocked by pretreatment with 
scopolamine. Their findings supported the hypothesis that the loss of 
consciousness produced by propofol is mediated, at least in part, via 
interruption of central cholinergie muscarinic transmission. The results of 
our study may provide a possible explanation for their study although the 
site of action of propofol in the CNS to produce unconsciousness is still 
not known. 
ln conclusion, this study demonstrates that the method with a volume 
of distribution constraint, derived from the cerebellum, yielded the best 
estimates of k3 and is superior to the method with positivity constraints in 
the regions with low and intermediate muscarinic receptor density. Our 
results may also indicate a prapofol-related reduction in muscarinic 
receptor binding in CNS. However, the high variability of k3 related to the 
irreversible binding property of the tracer prevents us fram reporting 
statistically significant differences. Therefore it may be better to repeat a 
similar PET study with a more suitable radioligand, such as the reversible 
tracer NMPB (Zubieta et al., 2001). Furthermore, our study did not provide 
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any information about the possible change of endogenous Ach. Recently a 
new tracer, 3-[11C]NMPYB (Skaddan et aL, 2002), has been designed for 
the express purpose of measuring changes in endogenous Ach, which 
points towards another future research direction. 
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Chapter 3. How would you Lose and Regain your 
Consciousness? A PET Study of Unconsciousness Induced by 
Propofol and Consciousness Restored by Physostigmine. 
ln the last chapter, our results have suggested a propofol-related 
reduction in muscarinic receptor binding in CNS, which supports the 
hypothesis that the loss of consciousness produced by propofol is 
mediated, at least in part, via interruption of central cholinergie muscarinic 
transmission. This chapter investigates which brain function changes 
specifically linked to the difference in level of consciousness by examining 
thalamic and cortical neural activities during successful and failed 
attempts to antagonize propofol-induced unconsciousness with 
physostigmine. 
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3.1 Abstract 
This work aims at identifying the brain function changes specifically 
linked to changes in levels of consciousness, and separate these fram the 
non-specifie drug related physiological alterations. To identify the changes 
specifically related to consciousness we used physostigmine (an 
anticholinestherase) to restore consciousness (defined as responsiveness 
to verbal commands) in 4 subjects anesthetized with a constant 
concentration of prapofol (given with a computer-contralled pump at the 
lowest concentration praducing unconsciousness). The administration of 
propofol was maintained at the same plasma concentration after 
physostigmine infusion. PET measures of regional cerebral blood flow 
(rCBF) were obtained during baseline (BASE), unconsciousness (UNCO), 
physostigmine (PHYSO) and recovery (RECO). Changescommon to the 
BASE-UNCO and PHYSO-UNCO contrasts were considered functionally 
linked to the change in level of consciousness independently of any non-
specifie effect of prapofol. These changes occurred in the right thalamus 
and bilaterally in the precuneus where rCBF decreased significantly during 
anesthesia and increased significantly after physostigmine. The 
consciousnes restored by physostigmine related to the significant rCBF 
increases in bilateral thalami and cuneus. Data fram 3 additional subjects 
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who failed to wak~ up after physostigmine revealed significant rCBF 
decreases in the right thalamus and bilaterally in the precuneus during 
anesthesia but no significant increase after physostigmine. We conclude 
that the thalamus and precuneus/cuneus jointly play a critical role in 
controlling the changes in the level of consciousness during general 
anesthesia. 
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3.2 Introduction 
The loss of consciousness induced by general anesthetics has been 
considered ta involve the same brain structures as those involved in the 
control of the sleep-awake continuum (Heinke and Schwarzbauer, 2002). 
Findings of electrophysiological works in animais (Angel, 1993) suggest 
that the primary basis of anesthesia may be the disruption of sensory 
information processing through the thalamus. This idea is consistent with 
the recent findings from human positron emission tomography (PET) 
studies. Using the 18FDG PET technique, Alkire and co-workers have 
examined the effects of propofol and two volatile general anesthetics, 
isoflurance and halothane, on neuronal activity in humans (Alkire et aL, 
1995, 1997, 1999, 2000). Their results revealed decreased regional 
metabolism (rCMRgl) in the thalamus, in many cortical areas and in the 
cerebellum during unconsciousness. Using the H2015 PET technique, 
Bonhomme et al. (2001) and Fiset et al. (1999) investigated the regional 
cerebral blood flow (rCBF) during graded changes of propofol anesthesia 
with and without vibrotactile stimuli. These results demonstrated that 
unconsciousness was consistently associated with reduced rCBF in the 
thalamic and in many cortical areas during the resting condition as weil as 
with suppression of thalamus and cortical activations caused by 
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somatosensory stimulation (vibration). In addition, Veselis et al. (1997B) 
have shown that sedative concentrations of midazolam decrease rCBF in 
the thalamus and in many cortical areas. However, these PET studies did 
not rule out the possibility that a change in neural activity (such as 
reduced rCBF or rCMRgl) and a concurrent alteration of the level of 
consciousness may be independent of each other but affected in a similar, 
concentration-dependent manner by the anesthetics. 
To circumvent this problem, we have developed a strategy using the 
drug physostigmine, an inhibitor of acetylcholinesterase, which increases 
synaptic levels of actycholine (Ach). It reverses the effects of anesthesia in 
animais (Horrigan, 1978; Roy and Stullken, 1981; Zucker, 1991) and 
humans (Hill et al., 1977; Meuret et aL, 2000; Plourde et aL, 2003). In this 
chapter, we examined thalamic and cortical neural activities during 
successful and failed attempts to antagonize propofol-induced 
unconsciousness with physostigmine. 
3.3 Methods 
3.3.1 Subjects 
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The study was approved by the Research Ethics Committee of the 
Montreal Neurological Institute and Hospital. Eight healthy subjects 
participated in the study, ail underwent a comprehensive medical 
evaluation and had no history of neurological, psychiatrie, or respiratory 
problems. Subjects fasted for at least 8 hours prior to induction of 
anesthesia and were given sodium citrate orally (0.3 M, 30 ml, BDH, 
Toronto, Ontario, Canada) at their arrivai in the positron emission 
tomography (PET). One subject was excluded from data analyses as the 
concentration of propofol was not consistently maintained during 
physostigmine infusions. Therefore seven healthy volunteers (mean age, 
30 years; range, 22-40 years) completed the study. There were four 
subjects who woke up after injecting of physostigmine (responders). The 
ages of the four subjects were 22, 29, 29, 40, three of them were male 
and one is female. Three subjects who did not wake up after the injection 
of physostigmine (non-responder) were ages 28, 28, 32 and were ail male. 
3.3.2 Instrumentation and safety monitoring 
Anesthesia monitoring includes EEG, pulse oximetry, blood pressure 
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measure and determination of inspired and expired concentration of 
oxygen and carbon dioxide. The Patient State Index (PSI) was recorded 
with a 4-channel PSA 4000 monitor (Physiometrix, MA, USA). PSI is a 
quantitative feature derived from EEG that displays clear differences 
between hypnotic states (Kearse, 1998), but consistency across 
anaesthetic agents within the state (Sebel, 1997). EEG data were 
obtained in ail three non-responders but EEG data were not obtained in 
two of four responders due to a problem with the technique. An 
intravenous catheter was placed in the right forearm for drug infusion. 
Another catheter was inserted in the left radial artery for procurement of 
blood samples for determination of propofol plasma levels (Plummer et al., 
1987) and radiotracer activity via subsequent counting in aNal well-
counter. Propofol assay were conducted in Dr. France Varin' s Lab, 
Univerisity of Montreal. Oxygen was administered at a rate of 3L1min 
through nasal prongs. Subjects were blindfolded, and ambient noise was 
kept to a minimum. 
3.3.3 Propofol infusion 
Propofol was given using a computer controlled infusion pump and 
the infusion program STANPUMP. This program uses pre-determined 
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population pharmacokinetics, the volunteer's pertinent covariates, and a 
multi-exponential infusion algorithm to quickly reach and maintain a target 
plasma concentration (Tackley et al., 1989). Propofol plasma 
concentrations of 2.0 ug/ml were targeted at beginning and increased in 
0.5 ug/ml increments until unconsciousness was achieved. 
Unconsciousness was defined as the loss of response to verbal 
commands (" Move your toes, raise your thumb."). These 
concentrations were compatible with safe, spontaneous breathing. Once 
unconsciousness was reached, PET scanning was delayed by 10 minutes 
to allow for blood-brain equilibration of propofol concentrations (Dutta S et 
al., 1998). The constant concentration of propofol was maintained by 
computer-controlled infusion scheme during physostigmine infusion. 
3.3.4 Experimental design 
Two PET scans were conducted for each condition during wakefulness 
baseline (BASE), unconsciousness induced by propofol (UNCO), 
physostigmine infusion (PHYSO), and recovery (RECO) (Figure 3-1). The 
first two scans were obtained in the waking, unmedicated state. After the 
subject was given propofol at the lowest concentration sufficient to 
produce unconsciousness, the second series of two scans were obtained 
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Figure 3-1: Experimental design 
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Two PET scans were conducted for each condition during wakefulness 
baseline (BASE), unconsciousness induced by propofol (UNCO), 
physostigmine infusion (PHYSO), and recovery (RECO) 
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With a constant concentration of propofol maintained by a computer-
controlled infusion pump, the subjects were given a bolus of 
physostigmine (28 ug/kg) combined with glycopyrrolate (4.2 ug/kg), 
followed by continuous infusion of physostigmine (28 ug/kg/hr) combined 
with glycopyrrolate (4.2 ug/kg/hr) for 30 minutes. Glycopyrrolate is an anti-
muscarinic agent given to prevent the peripheral side effects of 
physostigmine. It dose not cross the blood brain barrier. The third series of 
two PET scans were obtained after subjects regained consciousness or, if 
they did not regain consciousness, 10 minutes after the physostigmine 
bolus. The fourth series of two PET scans were obtained after propofol 
and physostigmine had been stopped for 20 minutes and subjects were 
completely awake. Arterial blood samples for propofol assay were taken 4 
min before the commencement of each scan during propofol, 
physostigmine infusion, and recovery. 
3.3.5 Data acquisition 
PET scans were obtained using a CTI/Siemens HR +, 32-rings, 63-
slices tomograph. The H215Q bolus technique was used. Counts were 
measured during a 3-min scan after a 10-mCi H2150 bolus injection into a 
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vein of the right verltra1 forearm. To allow for calculation of the absolute 
value of CBF, arterial blood samples were acquired throughout the 
scanning period using the catheter placed into the left radial artery. Arterial 
blood radioactivity was automatically sampled, corrected for delay and 
dispersion (Vafaee, 1996), and calibrated with respect to the tomograph. 
To facilitate localization of the regional change in rCBF, each subject 
underwent an MRI scan on a separate occasion (high-resolution, T1-
weighted, 1.5 T, 160 contiguous sagittal slices, 1 mm thick). 
3.3.6 PET data analysis 
3.3.6.1 K1 map 
The absolute CBF was calculated for the whole brain for each scan 
of each subject. We used the two-compartment, three-weighted integral 
method of Ohta et al. (1996). Cerebral perfusion maps (K1 maps) were 
generated for each 3-min dynamic scan using the native PET images 
across ail frames. Mean whole-brain CBF values were then obtained by 
averaging the K1 maps. Okazawa and Vafaee (2001) demonstrated that 
this method could provide rCBF values that are less influenced by 
vascular radioactivity. 
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To identify th~ brain regions where propofol and physostigmine 
induced changes in blood flow beyond those observed globally, we 
analyzed the effects of propofol on normalized rCBF. The K1 images were 
normalized for differences in global CBF by means of ratio normalization; 
i.e., the count at each voxel (3-dimensional image element) was divided 
by the mean counts calculated across ail brain voxels (Fox, 1988). The 
normalized K1 image were co-registered with individual MRls (Woods, 
1993) and transformed into a standardized stereotaxie space by means of 
an automated feature-matching algorithm (Collins, 1994). 
3.3.6.2 T statistic maps 
Statistical analysis of rCBF was performed using normalized rCBF of 
the 4 responders and 3 non-responders. Ali the calculations were carried 
out for each of the three-dimensional volume elements (voxels) 
constituting a volume. The size of a voxel was 1.34x1.72x1.5 mm in x,y,z 
dimensions, respectively. To assess the differences in rCBF distribution 
during the different conditions of experiment, we calculated subtraction t-
statistic maps between different conditions with 2 scans for each condition. 
At-value was calculated for each voxel by dividing the mean CBF 
difference by its standard deviation pooled across ail brain voxels 
(Worsley, 1992). Four different subtractions were carried out as follows: 
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BASE-UNCO, PHYSO-UNCO, PHYSO-BASE, and RECO-BASE. A 
BASE-UNCO subtraction was aimed at revealing effects of 
unconsciousness induced by propofol. A PHYSO-UNCO subtraction was 
generated to evaluate the consciousness restored by physostigmine in 
four responders. A PHYSO-BASE subtraction was aimed at revealing the 
effect of propofol and physostigmine. A RECO-BASE subtraction was 
generated to evaluate the effect of residual propofol and physostigmine. 
3.3.6.3 Conjunction analysis 
The functional conjunction between the BASE-UNCO and PHYSO-
UNCO subtractions in four responders is the changes in the level of 
consciousness. In order to find the brain regions that are specifically linked 
to the change in the level of consciousness, we performed the conjunction 
analysis between these two subtraction T maps, which reveals the brain 
regions that are both deactivated by propofol-induced unconsciousness 
and activated by physostigmine-restored consciousness. 
3.3.6.4 Spherical region-of-interest analysis 
ln arder to demonstrate the relative rCBF changes in the conjunction 
areas (right thalamus and precuneus) in four responders, we extracted the 
rCBF value using a spherical region-of-interest (4 mm radius) centered at 
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the middle of conjunction areas of right thalamus (5,-17,8) and precuneus 
(1,-67, 32). 
3.3.6.5 Region-based regressions 
We also carried out the region-based regression to reveal brain 
regions with blood flow response similar to that present in right and left 
thalamus in four responders. We regressed rCBF-change in ail other 
voxels with the voxel (8,-18,9) that has the hightest t value in right 
thalamus in the subtractions of PHYSO-UNCO and the voxel (-7, -16, 6) 
that has the hightest t value in left thalamus in the subtractions of PHYSO-
BASE. We selected different regression seed points fram the subtractions 
of PHYSO-UNCO and PHYSO-BASE because the right thalamic 
activation in the subtraction of PHYSO-UNCO may be related to the 
physostigmine-restored consciousness and the left thalamic activation in 
the subtraction of PHYSO-BASE may be related to drug effect. 
3.3.6.6 Spherical region-of-interest analysis 
ln order to further demonstrate the differences between the 
responders and non-responders, we extracted the rCBF value using a 
spherical region-of-interest (4 mm radius) centered at the voxel with the 
highest T value in right thalamus (8,-18,9) and left thalamus (-3,-16,8). 
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3.3.7 Statistical analysis 
We analyzed the variability of HR, MAP, PC02, Sp02, global CBF, 
and relative rCBF extracted with spherical region-of-interest method 
across four experimental conditions using an one-factor within-subjects 
ANOVA and Tukey's HSD for post hoc comparisons. For the T statistical 
map of subtraction, region-based regression, and event regression in 
responders and non-responders, the presence of significant focal changes 
was tested by a method based on three-dimensional Gaussian random 
field theory, which corrects for the multiple comparisons involved in 
searching across a volume (Worsley et aL, 1992). Values equals to or 
exceeding a criterion of t = 4.5 were considered statistically significant (p < 
0.0001; two tailed, uncorrected). Correcting for multiple comparisons, a t 
value of 4.5 yields a false-positive rate of 0.05 in 500 resolution elements 
(each ofwhich has dimensions 7.7 x 18 x 18 mm), which is approximately 
the volume of brain gray matter. For BASE - UNCO subtraction of three 
non-responders, the directed searches of rCBF changes in the thalamus 
were performed in regions previously shown to be involved in 
unconsciousness induced by general anesthetics. The significant 
threshold for these directed searches was t=2.63 (p<0.05, two-tail) , after 
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corrected for multiple comparisons involving a 6-resel search volume 
(Worsley et al., 1992). 
3.4 Results 
3.4.1 Four responders 
3.4.1.1 Monitoring 
Seven of eight volunteers enrolled completed the study. For four 
responders, the MAP during unconsciousness was significantly lower than 
those during other experimental stages (p < 0.05); the PaC02 during 
unconsciousness was significantly higher than those during other 
experimental stages (p < 0.05); the HR during physostigmine infusion was 
significantly higher than those during other experimental stages (p < 0.05); 
There were no significant differences in HR and global cerebral blood flow 
(gCBF) among four experimental periods (p > 0.05) (Table 3-1). The 
measured propofol concentrations were as follows (mean ± SO): 
unconsciousness, 3.20 ± 0.75 /-tg/ml; physostigmine, 2.85 ± 0.53 /-tg/ml; 
recovery, 1.03 ± 0.22 /-tg/ml. For two subjects with EEG monitoring, the 
values of Patient State Index (PSI) were as follows: baseline state, 99, 99; 
unconsciousness state, 26, 21; physostigmine state, 87, 88; recovery 
state, 95, 92. 
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Table 3-1: Vital Signs and global CBF of four responders 
GlobeCBF 
(mlll OOml.min) 
PC02 
(mmHg) 
P02 
(mmHg) 
HR (beats.min- I ) 
MAP 
(mmHg) 
Baseline 
41.9 ± 4.6 
41.8 ± 2.5 
207.8 ± 23.0 
60 ± 1.6 
90.5 ± 5.8 
Unconsciousness Physostigmine Recovery 
41.2 ± 6.8 38.7 ± 2.9 40.5 ± 6.2 
48.5 ± 2.4 # 42.3 ± 3.9 43.3 ± 3.8 
221.3±40.1 176.3 ± 34.3 176.3 ± 34.3 
60.5 ± 1.7 102 ± 14.3 # 70.5 ± 8.2 
69.2 ± 5.4 # 80.3 ± 4.0# 87.0 ± 3.0 
Vital signs and global CBF of four subjects who woke up after 
physostigmine injection (mean ± SE). # P<O.05 compared with other 
scans. 
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3.4.1.2 Subtraction analysis 
For the four subjects who woke after physostigmine infusion, the 
comparison between the baseline and unconsciousness states 
demonstrated that the relative rCBF decreased significantly in the 
unconsciousness state in the bilateral precuneus, the right thalamus, and 
some convex parietal regions, in comparison with the baseline state 
(Table 3-2, Figure 3-2). The comparison between the unconsciousness 
and physostigmine states demonstrated that the relative rCBF increased 
significantly in the physostigmine state in several regions, the bilateral 
thalamus, the bilateral cuneus, bilateral precentral gyrus, left medial frontal 
gyrus and the right fusiform (Table 3-3, Figure 3-3). The comparison 
between the physostigmine and baseline states demonstrated that the 
relative rCBF increased significantly in the physostigmine state in the 
following regions, the bilateral precentral gyrus, the left medial thalamus, 
right medial frontal gyrus, the left insula, the right cingulate gyrus and left 
cuneus, in comparison with the baseline state (Table 3-4, Figure 3-4). 
The comparison between the recovery and baseline states demonstrated 
that the relative rCBF increased significantly in the recovery state in the 
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Table 3-2: Areas of significant relative rCBF decreases during propofol-
induced unconsciousness in four responders 
Anatomie al location 
Positive peaks 
Right precuneus 
Left precuneus 
Right precuneus 
Right thalamus 
Right precuneus 
Left inferior parietal lobule 
Right superior parietal lobule 
Left orbital gyrus 
Right fusiform gyrus 
Negative peaks 
Left insula 
Left anterior cingulate 
Left medial frontal gyrus 
BA 
7 
31 
7 
7 
40 
7 
47 
18 
13 
32 
6 
x 
15 
-1 
5 
9 
-48 
29 
-12 
20 
-42 
-3 
Talairach Coordinates 
y 
-61 
-50 
-68 
-16 
-78 
-50 
-59 
34 
-88 
-7 
32 
-14 
z 
48 
30 
38 
Il 
57 
54 
63 
-23 
-15 
9 
21 
48 
T 
7.18 
6.99 
6.82 
6.22 
5.75 
5.41 
4.64 
4.62 
4.62 
-5.61 
-5.04 
-4.67 
Clusters of voxels showing statistically significant relative rCBF reductions 
in the BASE minus UNCO subtraction. Only areas with a T score> 4.5 (P 
< .05, corrected with multiple comparison) are considered significant. 
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Figure 3-2: Regions with significant decrease in relative rCBF during 
propofol-induced unconsciousness 
6.5 
1 
X=6 
4.5 
Y=-14 Y=-68 
The T statistical map of BASE minus UNCO subtraction revealed that the 
relative rCBF decreased significantly in the bilateral precuneus, the right 
thalamus during the unconsciousness state. The range of positive values 
for the T map is coded by the color scale. 
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Table 3-3: Areas s>f significant relative rCBF Increases and decreases 
during consciousness restored by physostigmine 
Anatomicallocation BA Talairach Coordinates T 
X Y z 
Positive peaks 
Left thalamus -3 -16 8 11.5 
Right thalamus 8 -18 9 11.18 
Right cuneus 18 5 -74 18 9.15 
Right cuneus 17 3 -87 9 8.29 
Right cuneus 18 24 -87 26 6.6 
Left cuneus 19 -12 -83 35 6.55 
Left cuneus 19 -21 -88 23 6.3 
Left putamen -24 -1 5 6.02 
Left precentral gyrus 4 -40 -13 44 5.5 
Right precentral gyrus 6 56 -7 35 5.35 
Left medial frontal gyrus 6 -1 -26 63 4.85 
Right fusiform gyrus 18 20 -83 -20 4.61 
Negative peaks 
Left parahippocampal gyrus 36 -31 -19 -21 -5.01 
Right insula 38 35 -15 -4.9 
Right gyrus rectus 25 9 20 -18 -4.88 
Right parahippocampal gyrus 20 35 -16 -21 -4.84 
Left medial Frontal Gyrus 8 -12 30 42 -4.74 
Right medial Frontal Gyrus 8 28 29 36 -4.68 
Clusters of voxels showing statistically significant relative rCBF increases 
(positive peaks) and decreases (negative peaks) in the PHYSO minus 
UNCO subtraction. Only areas with a T score> 4.5 (P < .05, corrected 
with multiple comparison) are considered significant. 
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Figure 3-3: Regions with significant increase in relative rCBF during 
consciousness restored by physostigmine 
11.5 
1 
X=2 
4.5 Y=-17 Y=-75 
The T statistical map of PHYSO minus UNCO subtraction revealed that 
the relative rCBF Increased significantly in the bilateral cuneus and the 
bilateral thalami during the consciousness restored by physostigmine. The 
range of positive values for the T map is coded by the color scale. 
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Table 3-4: Areas with significant relative rCBF changes comparing the 
physostigmine state to baseline state 
Anatomicallocation BA Talairach Coordinates T 
x y Z 
Positive peaks 
Left precental gyrus 4 -42 -14 42 7.35 
Right precental gyrus 4 47 -Il 42 6.31 
Left thalamus -7 -16 6 6.22 
Right medial frontal gyrus 6 -25 66 6 
Left insula 13 -40 -11 Il 5.36 
Right cingulate gyrus 24 7 3 47 5.02 
Right anterior cingulate gyrus 32 4 36 Il 4.93 
Left cuneus 18 -3 -81 20 4.7 
Negative peaks 
Right precuneus 7 15 -61 46 -6.4 
Left rectal gyrus Il -11 32 -21 -6.27 
Left cingulate gyrus 31 -1 -49 29 -5.74 
Right parahippocampal gyrus 30 -13 -20 -5.57 
Left superior frontal gyrus 9 -40 36 30 -5.53 
Right cingulate gyrus 31 20 -42 39 -5.34 
Right inferior temporal gyrus 20 55 -23 -21 -5.13 
Right inferior temporal gyrus 20 52 -47 -9 -4.93 
Right middle frontal gyrus 46 43 36 23 -4.83 
Fusiform Gyrus 37 -35 -59 -20 -4.71 
Superior Frontal Gyrus 6 -16 30 59 -4.59 
Clusters of voxels showing statistically significant relative rCBF increases 
(positive peaks) and decreases (negative peaks) in the PHYSO minus 
BASE subtraction. Only areas with a T score> 4.5 (P < .05, corrected with 
multiple comparison) are considered significant. 
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Figure 3-4: Regions with significant changes in relative rCBF when 
comparing the physostigmine state to baseline state 
7.4 
X=-42 
Z=42 
4.5 y= -14 
The T statistical map of PHYSO minus BASE subtraction revealed that the 
relative rCBF increased significantly in the left thalamus and bilateral 
precental gyrus when comparing the Physostigmine to baseline state. The 
range of positive values for the T map is coded by the color scale. 
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following regions, the left medial thalamus, left anterior cingulated gyrus, 
bilateral medial frontal gyrus, bilateral precentral gyrus, and left insula, in 
comparison with the baseline state (Table 3-5, Figure 3-5). 
3.4.1.3 Conjunction analysis 
The functional conjunction between BASE-UNCO and PHYSO-
UNCO subtractions reflects the changes in the level of consciousness. In 
order ta find the brain regions that are specifically linked ta the change in 
the level of consciousness, we performed the conjunction analysis 
between these two subtraction T maps. We found the conjunction areas 
were right thalamus and bilateral precuneus (Figure 3-6). 
3.4.1.4 Spherical region-of-interest analysis 
Figure 3-7 shows the relative rCBF values extracted using a 
spherical region-of-interest (4 mm radius) centered at the middle of 
conjunction areas of right thalamus (5,-17,8) and precuneus (1,-67, 32) in 
four experimental periods. We found that the relative rCBF during 
unconsciousness was significantly lower that of other experimental 
periods (P<O.01), while there is no significant changes in global CBF. 
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Table 3-5: Areas with significant relative rCBF changes comparing the 
recovery state to baseline state 
Anatomicallocation BA Talairach Coordinates T 
x y z 
Positive peaks 
Left thalamus -7 -16 8 5.88 
Left anterior cingulate 32 -1 32 24 5.77 
Right medial frontal gyrus 6 3 -26 66 5.32 
Right precentral gyrus 4 46 -13 44 5.22 
Left insula 13 -42 -9 Il 5.07 
Left cingulated gyrus 31 -3 -16 47 4.97 
Right medial frontal gyrus 6 5 3 48 4.85 
Left precentral gyrus 4 -42 -16 45 4.84 
Left medial frontal gyrus 32 -3 6 47 4.74 
Negative peaks 
Left rectal gyrus Il -11 32 -21 -6.23 
Right precuneus 7 16 -61 48 -5.93 
Right parahippocampal gyrus 29 -13 -20 -5.56 
Right fusiform gyrus 37 50 -45 -11 -4.58 
Clusters of voxels showing statistically significant relative rCBF increases 
(positive peaks) and decreases (negative peaks) in the RECO minus 
BASE subtraction. Only areas with a T score> 4.5 (P < .05, corrected with 
multiple comparison) are considered significant. 
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Figure 3-5: Regions with significant changes in relative rCBF when 
comparing the recovery state to baseline state 
5.9 
1 
X=-7 
Z=8 
4.5 y= -16 
The T statistical map of RE CO minus BASE subtraction revealed that the 
relative rCBF Increased significantly in the left thalamus, cingulated gyrus, 
and bilateral precental gyrus when comparing the Recovery to Baseline 
State. The range of positive values for the T map is coded by the color 
scale. 
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Figure 3-6: Conjunctive areas between subtraction BASE-UNCO and 
subtraction PHYSO-UNCO 
X=6 
Y=-13 Y=-67 
Conjunctive analysis identifying common brain regions both deactivated 
by propofol-induced unconsciousness and activated by consciousness 
restored by physostigmine: right medial thalamus and bilateral precuneus. 
The cutoff T value equals to 4. 
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Figure 3-7: Relative rCBF in thalamus and precuneus 
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The relative rCBF values extracted using a spherical region-of-interest (4 
mm radius) centered at the middle of conjunction areas of right thalamus 
(5,-17,8) and precuneus (1,-67, 32) in four experimental periods (* P<O.01) 
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3.4.1.5 Region-based regressions 
ln order to reveal brain regions with blood flow response similar to 
that present in right thalamus, the rCBF-changes in ail other voxels were 
regressed with the voxel with the highest t value in right thalamus (8, -18, 
9). We found that this voxel was positively covariated with nearby voxel in 
right thalamus, bilateral cuneus and precuneus, and left putamen (Table 
3-6, Figure 3-8). The rCBF-changes in ail other voxels were also 
regressed with the voxel with the highest t value in left thalamus (-7, - 16, 
6). We found that this voxel was positively covariated with nearby voxel in 
left thalamus, right thalamus, medial frontal gyrus, bilateral putamen, left 
cuneus and other cortical areas (Table 3-7, Figure 3-9). 
3.4.2 Three non-responders compared with four responders 
3.4.2.1 Monitoring 
For three subjects who did not wake up after receiving physostigmine, 
the global CBFs during unconsciousness and physostigmine were 
significantly higher than those during baseline and recovery stages (p < 
0.05); the PaC02 values during unconsciousness and physostigmine 
were higher than those during baseline and recovery stages but without 
reaching statistical significance; the HR during physostigmine infusion was 
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Table 3-6: CBF co-variations with the rCBF changes in the right medial 
thalamus 
Anatomical location 
Positive co-variations 
Right thalamus 
Rightcuneus 
Rightcuneus 
Right cuneus 
Right precuneus 
Left putamen 
Left precuneus 
Left cuneus 
Negative co-variations 
Left frontal cingulate gyrus 
Left frontal cingulate gyrus 
BA 
18 
18 
19 
7 
31 
19 
9 
8 
x 
9 
9 
25 
16 
-24 
-4 
-15 
-8 
-13 
Talairach Coordinates 
y 
-18 
-73 
-88 
-88 
-61 
-2 
-52 
-85 
37 
25 
z 
Il 
17 
9 
24 
50 
6 
32 
32 
26 
38 
T 
10.48 
7.25 
7.04 
5.07 
5.03 
4.87 
4.84 
4.79 
-4.54 
-4.54 
Clusters of voxels showing statistically significant co-variations with rCBF 
changes in right thalamus (8, -18, 9). Only areas with a T score> 4.5 (P < 
0.05, corrected with multiple comparison) are considered significant. 
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Figure 3-8: Region-based regression with the right medial thalamus 
10.5 
1 
X=7.4 
Z=9.4 
4.5 Y=-16.9 
The rCBF changes in the areas of the nearby right thalamic voxels, 
cuneus, precuneus have a significant positive regression with the rCBF 
changes in the source region of the right thalamus (8, -18, 9), the right 
thalamic voxel with the highest T value for ail subtractions. 
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Table 3-7: CBF cQ-variations with the CBF in the left medial thalamus 
Anatomicallocation BA Talairach Coordinates T 
x y z 
Positive co-variations 
Left thalamus -5 -18 8 12.55 
Right thalamus 13 -18 5 7.06 
Right media! frontal gyrus 6 -23 66 5.75 
Left calcaine gyruS 18 -1 -76 21 5.6 
Right putamen 29 6 2 5.59 
Left putamen -16 12 3 5.58 
Right parietal-occipital gyrus 19 7 -78 41 5.4 
Left central gyrus 4 -40 -16 44 5.28 
Left insula 13 -40 -14 9 5.15 
Right putamen 32 -7 2 5.l2 
Right precentral gyrus 4 44 -11 42 4.82 
Negative co-variations 
Right parahippocampal gyrus 29 -11 -20 -13.39 
Right cingulate gyrus 31 21 -44 39 -lO.56 
Right cingulate gyrus 24 17 -13 42 -9.4 
Right precuneus 7 16 -59 47 -8.83 
Right medial frontal gyrus 6 4 -9 57 -8.18 
Left precentral gyrus 4 -17 -30 57 -8.12 
Left rectus gyrus 11 -11 34 -21 -7.73 
Right middle frontal gyrus 8 27 12 35 -6.59 
Right middle temporal gyrus 6 9 -25 54 -5.16 
Right fusiform gyrus 30 28 -56 2 -4.8 
The brain regions listed in this table showed significant positive (t > 4.5) 
and negative (t < -4.5) co-variations of CBF with that measured in the left 
medial thalamus(-7, - 16, 6 ). 
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Figure 3-9: Region-based regressions with the left medial thalamus 
12.6 
X=-5.4 
Z=7.5 
4.5 Y=-17.7 
The rCBF changes in the areas of neighbour left medial thalamic voxels, 
right medial thalamus, and several cortical areas have a significant 
positive co-variation of CBF with the rCBF in the source region of the left 
thalamus (-7, - 16, 6), the left thalamic voxel with the highest T value for 
ail subtractions. 
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significantly higher than those during other experimental stages (p < 0.05); 
the MAP during unconsciousness was significantly lower than those 
during baseline stages (p < 0.05) and the MAP during recovery was 
significantly higher than those during baseline stages (p < 0.05). There 
were no significant differences in P02 among four experimental periods (p 
> 0.05) (Table 3-8). The measured propofol concentrations with HPLC 
analysis were as follows (mean ± SO): unconsciousness state, 3.60 ± 2.70 
}lg/ml; physostigmine state, 3.40 ± 0.93 }lg/ml; recovery state, 1.20 ± 0.29 
/-tg/ml. Patient State Index (PSI) measured with EEG monitor were as 
follows (mean ± SO): baseline state, 89.0 ± 9.5; unconsciousness state, 
16.0 ± 11.8; physostigmine state, 18.0 ± 10.2; recovery state, 83.0 ± 7.8. 
3.4.2.2 Subtraction analysis 
For the three subjects who did not wake up after the physostigmine 
infusion, the comparison between the baseline and unconsciousness 
states demonstrated that the relative rCBF decreased significantly in the 
unconsciousness state in several discrete regions, namely, the bilateral 
precuneus, left cingulated gyrus, right angular gyrus, and right cuneus and 
thalamus (significant with directed search) in comparison with the baseline 
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Table 3-8: Vital signs and global CBF of three non-responders 
Globe CBF 
(rn1l1 OOrnl.rnin) 
PC02 
(mmHg) 
P02 
(rnrnHg) 
HR (beats.min'l) 
MAP 
(rnmHg) 
Baseline 
39.1 ±3.5 
43 ± 6.6 
228.3 ± 9.9 
62.3 ± 10.0 
79.3 ± 6.4 
Unconsciousness Physostigmine Recovery 
52.9 ± 8.5* 53.2 ± 6.7* 40.5 ± 2.6 
57.7 ± 6.4 56.3 ± 9.0 48.3 ± 2.1 
210.3 ± 69.2 254.9 ± 28.7 250.0 ± 24.6 
79.5 ± 7.5 109.3 ± 2.1 * 75.7 ± 5.5 
61.4 ± 9.7 * 67.9 ± 7.9 89.2 ± 3.6* 
Vital signs and global CBF of three subjects who did not wake up (non-
responders) after physostigmine injection (mean ± SE). * P<O.05 
compared with baseline 
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state (Figure 3-10,11,12, Table 3-9); the comparison between the 
unconsciousness and physostigmine states demonstrated that the relative 
rCBF increased significantly in the physostigmine state in only following 
regions, left cuneus, right lingual gyrus, and left thalamus (T=3, borderline 
significant with directed search) in comparison with the unconsciousness 
state (Figure 3-10,11,12; Table 3-10). 
3.4.2.3 Spherical region-of-interest analysis 
Figure 3-13 and 3-14 show the relative rCBF values extracted using a 
spherical region-of-interest (4 mm radius) centered at right thalamus (8,-
18,9) and left thalamus (-3,-16,8) in four experimental periods. We found 
that the relative rCBF during unconsciousness was significantly lower that 
of other experimental periods (P<0.01) in four responders, while there 
were no significant changes in relative rCBF in three non-responders. 
3.4.2.4 Event regression analysis 
The relationship between rCBF and the event of regaining 
consciousness during physostigmine infusion was evaluated by ANCONA. 
The event of regain consciousness during physostigmine infusion was 
defined as "awake" . The variable "awake" equals 1 for four 
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Table 3-9: Regions with significant decrease in relative rCBF during 
propofol-induced unconsciousness in three non-responders 
Anatomicallocation BA Talairach Coordinates T 
x y z 
Positive peaks 
Right precuneus 7 4 -62 33 7.4 
Left precuneus 7 -17 -73 48 5.7 
Left precuneus 7 -4 -76 42 5.1 
Left precuneus 19 -5 -83 45 5.1 
Left posterior cingulated gyrus 31 -4 -40 38 4.8 
Right angu1ar gyrus Il 39 -64 45 4.7 
Right thalamus 7 -11 Il 4.3* 
Negative peaks 
Right parahippocampal gyrus 23 -7 -20 -6.3 
Left anterior cingu1ate gyrus 32 -5 17 30 -5.5 
Left illSula 13 -43 3 -2 -4.8 
Left cingulate gyrus 6 -1 -4 50 -4.7 
Clusters of voxels showing statistically significant relative rCBF reductions 
in the BASE minus UNCO subtraction. Only areas with a T score> 4.5 ( P 
< 0.05, corrected with multiple comparison) are considered significant. * 
Significant with directed research (P <0.05). 
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Table 3-10: Areas of significant relative rCBF increases and decreases 
during consciousness restored by physostigmine in three non-responders 
Anatomical location BA Talairach Coordinates T 
x y z 
Positive peaks 
Left cuneus 23 -4 -73 Il 7.3 
Right lingual gyrus 17 14 -95 -5 4.8 
Negative peaks 
Right inferior frontal gyrus 46 48 18 26 -4.6 
Clusters of voxels showing statistically significant relative rCBF increases 
(positive peaks) and decreases (negative peaks) in the PHYSO minus 
UNCO subtraction in three non-responders. Only areas with a T score> 
4.5 (P < 0.05, corrected with multiple comparison) are considered 
significant. 
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Figure 3-10: The coronal sections of t maps of subtraction BASE-UNCQ 
and subtraction PHYSQ-UNCQ in four responders (N = 4) and three non-
responders (N = 3) 
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6.5 
1 
11.5 
N=4 
Çj 
4.5 4.5 
Y=-14 Y=-17 
7.5 1 
N=3 
3 3 
Y=-12 Y=-17 
The coronal sections of t maps of subtraction BASE-UNCO revealed that 
significant rCBF reductions during unconsciousness in right medial 
thalamus were found in both responders and non-responders. The coronal 
sections of t maps of subtraction PHYSO-UNCO revealed that significant 
rCBF increase in bilateral medial thalamus were found in responders but 
not in non-responders during physostigmine-restored consciousness. 
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Figure 3-11: The sagittal sections of t maps of subtraction BASE-UNCO 
and subtraction PHYSQ-UNCQ in four responders (N = 4) and three non-
responders (N = 3) 
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The sagittal sections of t maps of subtraction BASE-UNCQ revealed that 
significant rCBF reductions during unconsciousness in right medial 
thalamus and precuneus were found in both responders and non-
responders. The sagittal sections of t maps of subtraction PHYSQ-UNCQ 
revealed that the significant rCBF increase in the medial thalamus and 
cuneus were found in responders but the significant rCBF increase in the 
cuneus were found in non-responders during physostigmine-restored 
consciousness. 
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Figure 3-12: The horizontal sections of T maps of subtraction BASE-
UNCO and subtraction PHYSO-UNCO in four responders (N = 4) and 
three non-responders (N = 3) 
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The sagittal sections of t maps of subtraction BASE-UNCO revealed that 
significant rCBF reductions during unconsciousness in right medial 
thalamus were found in both responders and non-responders. The sagittal 
sections of t maps of subtraction PHYSO-UNCO revealed that the 
significant rCBF increases in the bilateral medial thalamus and cuneus 
were found in responders but the significant rCBF increase in only the 
cuneus were found in non-responders during physostigmine-restored 
consciousness. 
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Figure 3-13: The relative rCBF in the right thalamus of four responders 
and three non-responders 
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Relative rCBF extracted using spherical ROI with 4 mm radius centred at 
8, -18, 9 in right thalamus (* P < 0.01 compared with other three conditions) 
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Figure 3-14: The relative rCBF in the left thalamus of four responders and 
three non-responders 
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Relative rCBF extracted using spherical ROI with 4 mm radius centred at 
-3, -16, 8 in left thalamus (* P < 0.01 compared with PHYSO and UNCO) 
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responders and 0 fqr three responders. On a voxel-by-voxel basis, rCBF 
values were co-variated with the variable "awake" for each subtraction. 
Figure 3-15 shows the results of event regression of subtraction between 
PHYSO and UNCO. There was a significant positive linear relationship 
between rCBF changes in left thalamus and the event of regain 
consciousness during physostigmine infusion. Figure 3-16 shows the 
results of event regression of subtraction between PHYSO and BASE. 
There was also a significant positive linear relationship between rCBF 
changes in left thalamus and the event of regain consciousness during 
physostigmine infusion. 
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Figure 3-15: Event regression of subtraction PHYSO - UNCO 
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The event regression of subtraction between PHYSO and UNCO revealed 
a significant positive linear relationship between rCBF changes in left 
thalamus and the event of regain consciousness during physostigmine 
infusion. 
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Figure 3-16: Event regression of subtraction PHYSO - BASE 
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The event regression of subtraction between PHYSO and BASE revealed 
a significant positive linear relationship between rCBF changes in left 
thalamus and the event of regain consciousness during physostigmine 
infusion. 
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3.5 Discussion 
The main goal of this study was to identify the brain function changes 
specifically linked to the difference in level of consciousness. We used 
physostigmine to restore consciousness induced by propofol. With the 
result of both successful and failed attempts to antagonize propofol-
induced unconsciousness with physostigmine, we were able not only to 
determine the brain function changes specifically linked to the difference in 
level of consciousness but also to determine the brain function changes 
specifically linked to effect of physostigmine. However, it is important to 
exclude the effect of other factors such as PaC02, which may confound 
our results and to understand the relationship between rCBF changes and 
brain functional activities. 
3.5.1 PaC02, rCBF changes, and brain activities 
It is weil known that changes in PaC02 alter global CBF dramatically 
(Kitaguchi et al., 1993, Strebel et al., 1994). The change in PaC02 is an 
important confounding factor, which is almost inevitable in this type of 
study unless ventilation is controlled by mechanical ventilation of an 
unresponsive participant. However, Kasiti et al. (2002) reported that 
mechanical ventilation of an unresponsive participant may cause a slight 
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hyperventilation during anesthesia despite the end tidal C02 being kept 
strictly at 4.5%. In spite of the hyperventilation, they also reported a 
significant decrease in rCBF in the precuneus and thalamus during 
anesthesia, which is same as the result of most studies with slight 
hypoventilation without mechanical ventilation. Therefore, the effects of 
changed PaC02 on relative rCBF appear to be minor in comparison with 
those of unconsciousness induced by general anesthetics. Distinct fram 
the effect on global CBF are regional absolute CBF changes related to 
PaC02, which can be also sought by normalizing the absolute rCBF by 
global CBF of each scan to obtain relative rCBF (Fox, 1988). It has 
recently been reported that the responses of rCBF to PaC02 changes are 
not uniform among brain areas. Ito et al. (2000) observed a significant 
relative rCBF increase in the pons, cerebellum, thalamus, and anterior 
cingulate gyrus and a significant relative rCBF decrease in temporal and 
occipital cortices during hypercapnia. In the current study, we found a 
significant relative rCBF decrease in right thalamus, bilateral precuneus, 
and other cortical areas, which was different from the effect they observed. 
The effect of hypercapnia can be easily distinguished fram the rCBF 
changes related to anesthetic-induced unconsciousness. An analysis of 
rCBF change in relation to PaC02 revealed a significant positive effect 
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(same direction as the effect of propofol-induced unconsciousness) from 
PaC02 changes itself only in left precentral gyrus, left superior frontal 
gyrus, and right angular gyrus, which is distant from most regions of the 
brain that demonstrates the unconsciousness effect for subtraction BASE 
- UNCO of four responders. Sa me as the results of previous reports (lto 
et al., 2000, Corfield et al., 1995), there was a significant negative effect 
from PaC02 changes itself in right parahippocampal gyrus and anterior 
cingulated gyrus, which is opposite direction as the effect of propofol-
induced unconsciousness. There was no significant effect from PaC02 for 
other five subtractions of four responders and ail subtractions for three 
non-responders. Therefore, the slight hypercapnia during 
unconsciousness in the present study does not influence our interpretation 
of the rCBF changes related to unconsciousness. 
The current study examines more directly the effect of drug on the 
rCBF response. Though neuronal activity was not directly measured, the 
functional coupling of regional cerebral blood flow and local cerebral 
glucose metabolism has been established in a wide range of experiments. 
As more than 85% of cerebral glucose is used by neurons and the 
remainder may at least partly account for metabolic processes in glial cells, 
monitoring of regional cerebral blood flow with PET mainly reflects 
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neuronal and more specifically synaptic activity (Jueptner and Wei 11er, 
1995). The neuronal synaptic activity, which is only indirectly measured by 
rCBF responses, represents the information transmission in the brain. 
Although a relationship between changes in brain activity and blood flow 
has long been a matter of speculation, the neural basis of rCBF changes 
and the fMRI signal was only recently demonstrated directly in 
experiments using combined imaging and intracortical recordings 
(Logothetis et aL, 2001; Logothetis and Pfeuffer, 2004). 
3.5.2 Mechanism of unconsciousness induced by general anesthetics 
3.5.2.1 Brain regions linked specifically to propofol-induced 
unconsciousness 
ln our current study, the results of BASE minus UNCO subtractions 
in four responders support our previous findings of significant decrease in 
rCBF in the precuneus, the right thalamus, and some parietal regions 
during unconsciousness (Fiset, 1999). Results of PHYSO minus UNCO 
subtractions in four responders revealed a new finding that a significant 
increase in rCBF was found in the regions of the bilateral thalamus, the 
bilateral cuneus, bilateral precentral gyrus, left medial frontal gyrus and 
the right fusiform during the physostigmine state. The functional 
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conjunction betweerl these two subtractions relates to the changes in the 
level of consciousness (Figure 3-17), which links to the anatomical 
conjunction between the brain regions deactivated by propofol and the 
brain regions activated by physostigmine. We found the most significant 
conjunction areas (T > 4) are right thalamus and bilateral precuneus. A 4-
mm spherical volume-of-interest analysis in the conjunction areas reveals 
that relative rCBF during unconsciousness was significantly lower that of 
other experimental periods. These functional changes common to the 
BASE-UNCO and PHYSO-UNCO contrasts were considered functionally 
linked to the change in level of consciousness independently of any non-
specifie effects of propofol and physostigmine as these effects have been 
removed. To our knowledge, there are no previous studies that have 
distinguished the brain activation caused by the direct effect of drug and 
the brain activation related to unconsciousness. Although some authors 
understand the possibility that the regions identified may have nothing to 
do with the regulation of consciousness, but may simply reflect those 
areas affected by the agents causing the unconsciousness (Alkire et al., 
2000). 
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Figure 3-17: Functional conjunction between subtraction BASE-UNCO 
and subtraction PHYSO-UNCO 
BASE-UNCO PHYSO - UNCO 
Physosti . mine 
The changes in the level of consciousness 
The functional conjunction between BASE-UNCO and PHYSO-UNCO 
subtractions reflects the changes in the level of consciousness, which is 
linked to the significant deactivations or activations in the right thalamus 
and bilateral precuneus. 
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The region-based regression with right thalamus reveals that rCBF 
changes in the bilateral precuneus and bilateral cuneus showed a 
significantly positive covariation with those in right thalamus, which 
suggested a close functional relationship between thalamus and 
precuneus/cuneus. On the voxel-by-voxel basis, a number of studies have 
examined the effects of propofol on the brain rCBF changes in healthy 
human subjects. Using covariation analysis, Fiset et al. (1999) and 
Bonhomme et aL, (2001) demonstrated that propofol reduced in a dose-
dependant manner normalized rCBF in specifie brain regions including the 
right medial thalamus, midline precuneus, and several other cortical areas. 
Using subtraction analysis, Veselis et al. (2004) revealed that significant 
decrease in rCBF in right medial thalamus, right precuneus, and other 
cortical areas. The medial thalamus and midline precuneus are the 
common brain regions that have significant reduction in rCBF with 
unconsciousness induced by propofol in ail these three studies, which is 
consistent with our finding in the conjunction analysis. 
Based on the resuts of current study together with the findings of 
previous studies of unconsciousness induced by propofol in healthy 
subjects, we hypothesize that the joint activities of the medial thalamus, 
midline precuneus/cuneus, other related cortical areas, contribute to the 
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unconsciousness induced by propofol. Ogawa et al. (2003) examined the 
effects of propofol on rCBF in patients with severe depression. Their 
results, which also revealed the reduction of rCBF in medial thalamus, 
precuneus, and other cortical areas, are almost entirely consistent with 
those reported in healthy subjects. These results suggested that the 
neural structures that are targeted by propofol are basically the same in 
severely depressed and normal subjects. 
3.5.2.2 Brain regions linked to unconsciousness induced by other 
anesthetics 
This hypothesis may be extended to the unconsciousness induced 
by other anesthetics. Veselis et al. (2004) studied the effect of thiopental 
on rCBF using PET imaging in 4 healthy volunteers. They found significant 
decreases of rCBF in bilateral precuneus and cuneus, bilateral cingulated 
gyrus, left cerebellum and fusiform gyrus but not in thalamus. Although 
they believed that the small sam pie size might have caused their failure to 
detect the significant decrease of rCBF in the thalamus, their results 
indicated the mechanism of unconsciousness induced by thiopental might 
be different with other general anesthetics. Kaisti et al. (2002) examined 
the effects of surgical levels of propofol and sevoflurane anesthesia on 
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cerebral blood flowin healthy subjects. They revealed significant relative 
rCBF decreases in the right medial thalamus (8, -26, 6), bilateral 
precuneus and cuneus, and other cortical areas during 1 MAC sevoflurane 
anesthesia. During propofol anesthesia, they also revealed the significant 
relative rCBF decreases in the bilateral precuneus but not in the thalamus. 
Alkire et al. (2000) demonstrated that both isoflurane and halothane 
caused specifie relative reduction of regional cerebral glucose metabolism 
primarily in right thalamus (10, -12, 18), left cuneus, medial frontal gyrus, 
inferior temporal gyrus, and cerebellum. Therefore, our hypothesis of 
mechanism of unconsciousness seems to also be valid for sevofluane, 
isoflurane, and halothane. In their early PET study of Midazolam, Veselis 
et al. (1997B) demonstrated that the significant rCBF decrease occurred in 
the dorsomedial thalamus, the cingulated gyrus, the insula, multiple areas 
in prefrontal cortex, and parietal and temporal association areas. A 
significant rCBF decrease was not detected in the precuneus and cuneus 
during midazolam infusion. It may indicate a different neuronal network for 
the unconsciousness induced by midazolam or just a technical limitation of 
early PET studies. 
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3.5.2.3 Thalamus and precuneus/cuneus as the key elements of neuronal 
network for consciousness and unconsciousness. 
The PET studies cited above have underscored the importance of 
the thalamus as a putative target of anesthetic action. Different 
subdivisions of thalamus have their specifie functions. The BASE-UNCO 
subtraction of this study and other two studies (Bonhomme et aL, 2001, 
Veselis et aL, 1997B) have revealed that general anesthetics significantly 
decreased the rCBF of the right medial dorsal nucleus of thalamus, which 
is closely related to the frontal association cortex. This pathway is reported 
to maintain vigilance and working memory (Kinomura et aL, 1996). 
Ogawa et al. (2003) reported that propofol significantly decreased the 
rCBF of the pulvinar nucleus of thalamus, which has been considered to 
communicate with the posterior part of the parietal lobes and occipital 
lobes (Burton et aL, 1976; Yeterian and Pandya, 1985). 
Most of PET studies cited above have also underscored the 
importance of the precuneus/cuneus as a putative target of anesthetic 
action. In the region-based regression analysis of right thalamus (Table 3-
6, Figure 3-8), significant positive co-variations were observed in the 
bilateral precuneus, bilateral cuneus, and left putamen. These results 
suggested a close functional relationship between right thalamus and 
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bilateral precuneus ,and cuneus, which strongly support our hypothesis 
that the medial thalamus, midline precuneus/cuneus, other related cortical 
areas constitute a neuronal network for consciousness and 
unconsciousness. In studies of normal conscious state, the precuneus has 
been identified as a major contributor to two relaxed conscious states: 
normal resting consciousness and the relaxation meditation in Yogo Nidra 
(Lou et aL, 1999; Kjaer and Lou, 2000). In the reflective self-awareness 
study, Kjaer et al. (2002) demonstrated differential activity in precuneus 
and angular gyri during reflection on own personality traits. The 
precuneus/posterior cingulate regions has repeatly been associated with 
episodic memory retrieval (Cabeza and Nyberg, 2000). Lou et al. (2004) 
presented evidence that the function of precuneus is particularly important 
to explicit self-representation. Ali these studies highlighted the importance 
of precuneus for maintaining normal conscious state. 
The published PET data described a very reproducible functional 
neuronal network in sleep, which again underscores the importance of 
thalamus and precuneus in a neuronal network for consciousness and 
unconsciousness. There are two types of sleep, slow wave sleep (SWS) 
and rapic eye movement (REM) sleep (stage 1). In humans, SWS is 
divided further into light (stage 2) and deep (stages 3,4) SWS. REM sleep 
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is astate with electriçal appearances and cerebral metabolic rate similar 
to those of wakefullness, accompanied by rapid eye movements and a 
profound relaxation of limb muscules (Zeman and Reading, 2005). One 
characteristic common to the sleep stages is reduced reflective self-
awareness (Kahan et al., 1997). In REM sleep, significant deactivations 
were found in precuneus and dorsolateral prefrontal, parietal, and 
posterior cingulate cortices while significant activations were found in 
thalamic nue/ei, limbic areas (amygdaloid complexes, hippocampal 
formation, anterior cingulate cortex), and brainstem. In deep SWS, 
significant deactivations were seen in precuneus, thalami, orbital frontal 
cortex, basal forebrain, anterior cingulate cortex, and parietal cortex 
(Marquet et al., 1997). Thus, reduction in activity in the precuneus is 
common to the two types of sleep, which again emphasizes the 
importance of precuneus for maintaining normal conscious state. The 
deactivation during deep SWS and activation during REM sleep in 
thalamus underline the importance of thalamus in the changes of level of 
consciousness. 
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3.5.2.4 The other elE;3ments of neuronal network for consciousness and 
unconsciousness. 
Although the thalamus and precuneus/cuneus have repeatedly 
shown to be deactivated during the unconsciousness induced by general 
anesthetics, the other cortical areas deactivated have varied from study to 
study. Conscious experiences have often been ascribed to the executive 
regions of the frontal lobe, especially prefrontal areas, and the cingulated 
gyrus. The prefrontal areas were deactivated during the unconsciousness 
induced by general anesthetics in Veselis et al. (1997, midazolam, BA 
10,11,47), Fiset et al. (1999, propofol, BA 11), Alkire et al. (2000, 
isoflurane and halothane, BA 47), Bonhomme et al. (2001, propofol, BA 10, 
46), Kaisti et al. (2002, sevoflurane, BA 9,10,46, propofol, BA 10,47) 
Ogawa et al. (2003, propofol, BA 46,47), and Veselis et al. (2004, propofol, 
BA 9,10,11,47, thiopental, BA 9). In our current study, the orbitofrontal 
gyrus (BA 47) was deactivated during the unconsciousness induced by 
propofol. These PET studies cited above have also underscored the 
importance of the prefrontal cortex as another putative target of anesthetic 
action. In the auditory vigilance task, large increases in rCBF were 
observed in the ventrolateral prefrontal cortex (BA 45, 47) as compared 
with the baseline state (Paus, 1997). This finding is consistent with the 
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results of lesion study (Wilkins et al., 1987) and supports a role of the 
prefrontal lobe in the allocation of the capacity-limited attention 
mechanisms. Dorsolateral prefrontal cortex was activated during working 
memory (Carpenter and Just, 2000). Kjaer et al. (2001) reported that the 
prefrontal cortex (BA 10,11) and precuneus (BA 31,7) were activated 
during awareness of visual verbal stimulation. During the 
unconsciousness induced by general anesthetics, the attention, 
awareness, and working memory were lost. Therefore, it is not surprising 
to see the deactivation in the different areas of prefrontal cortex. During 
SWS, the prefrontal cortex, especially orbital prefrontal cortex, was 
depressed more significantly than in other cortical areas (Maquet, 1997), 
which was supported by Hofle et al. (1997). Braun et al. (1997) and 
Andersson et al. (1998), who reported that both orbital prefrontal cortex 
and dorso-Iateral prefrontal cortex were deactivated during SWS. The 
prefrontal cortex was also deactivated during REM sleep (Marquet, 1996; 
Braun, 1997). Thus, the prefrontal cortex is involved in both normal sleep 
and unconsciousness induced by general anesthetics. 
The anterior cingulated cortex (ACC) sends dense projection to the 
motor cortex and receives extensive afferents fram the midline thalamus, 
which point to the importance of ACC in arausal state. Veselis et al. (1997) 
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reported that left anterior cingulated gyrus (BA 9-32) was deactivated 
during midazolam infusion, but it is a large deactivated cluster in left 
medial frontal cortex that extended to left ACC. Most of PET studies failed 
to detect significant rCBF reduction in ACC during the unconsciousness 
induced by general anesthetics, which may indicate that the inhibitory 
effects in the limbic system caused the minor rCBF response. In current 
study, the left ACC (BA 32) was activated during the unconsciousness 
induced by propofol in the four responders and three non-responders. It 
may be caused by the slight hypercapnia during unconsciousness. During 
hypercapnia, significant relative hyperperfusion in the thalamus and left 
ACC was observed (Ito et aL, 2000). Neural activation in the limbic system 
including ACC during C02-stimulated breathing has been reported in 
humans (Corfield et aL, 1995). Significant relative hyperperfusion in the 
thalamus and limbic system during hypercapnia may be related to C02-
stimulated breathing. We noted that the changes of rCBF in the thalamus 
caused by PaC02 are in the opposite direction of the changes of rCBF in 
thalamus found in this study. This finding may explain why some studies 
(Kaisti et al., 2002; Veselis et al., 2004) failed to detect the thalamic 
deactivation during the unconsciousness induced by anesthetics. As the 
ACC was deactivated during SWS, it was expected to find a reduction of 
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rCBF in the anterior cingulated gyrus during unconsciousness induced by 
general anesthetics. 80 far, we are not able to determine if the ACC is 
involved in the unconsciousness induced by general anesthetics. 
3.5.2.5 The hypothesis of Common Medline Core 
Kjaer et al. (2002) hypothesized that precuneus, angular gyri, and 
anterior cingulated gyri constitute a Common Midline Parietofrontal Core 
of reflective self-awareness and conscious states. Based on the above 
discussion, we can refine our hypothesis that the joint deactivations of a 
Common Midline Core, which includes the medial thalamus, midline 
precuneus/cuneus, prefrontal cortex and other related cortical areas, 
contribute to the unconsciousness induced by general anesthetics. The 
raie of ACC in the Common Midline Core of unconsciousness would 
require further investigation. 
3.5.3 Mechanism of consciousness restored by physostigmine 
3.5.3.1 Responders or non-responders 
Among the seven subjects in this study, four regained consciousnes 
after physostigmine infusion and three remained unconsciousness. In 
order to understand this phenomenon, we have to look at the relative dose 
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of propofol and physostigmine. As the experimental design of human 
studies is constrained by safety issue, the minimum dose of propofol was 
titrated to produce loss of consciousness in this study. This had practical 
relevance as subjects were able to maintain spontaneous respiration 
despite unconsciousness. The dose of physostigmine was also limited for 
reasons of safety. It is fortuitous that the dose of physostigmine was of 
sufficient magnitude such that it produced the intended effect, indicating 
that the dose-effect relationship between the relevant endogenous ligands 
and receptors were amenable to these pharmacological manipulations 
(Backman, 2004). 
Recently we used 11C-Benzotropine to study muscarinic receptor 
availability during propofol-induced unconsciousness (Xie, 2004 or 
Chapter 2). Our results showed that propofol produced a decrease in 
receptor availability (benztropine binding), which reflecting a decrease in 
central acetylcholine (ACh) binding, in several brain regions rich in 
muscarinic receptors. This would support the hypothesis that propofol 
affects Ach binding in two possible mechanisms. First, it is possible that 
propafal causes a change in canfarmational state of the muscarinic 
receptor from high to low affinity during unconsciousness so that it 
becomes less available for binding. Alternatively, it is possible that 
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propofol binds directly with the muscarinic receptor and prevents binging 
with ACh (or benztropine). Physostigmine inhibits cholinesterase and 
increases the amount of en doge nous ACh, which activates receptors to 
high affinity state or directly compete with propofol. Therefore, whether 
physostigmine reverses the unconsciousness induced by propofol 
depends on the relative dose of propofol and physostigmine. This finding 
may raise the possibility that depression of central cholinergie 
transmission is one of the common pathways mediating anesthesia-
induced unconsciousness. 
3.5.3.2 The brain region and consciousness restored by physostigmine 
We hypothesized that consciousness restored by physostigmine 
involved similar neuronal network but slightly different structures. The 
consciousnes restored by physostigmine related to not only activation in 
right thalamus but also the activation in the left thalamus (Figure 3-3; 
Table 3-3). The bilateral cuneus were activated in the consciousness 
restored by physostigmine while the bilateral precuneus were deactivated 
during the propofol-induced unconsciouseness. Comparing the results of 
PHYSO minus UNCO of four responders and three non-responders 
(Figure 10,11,12), we can see the activations in bilateral thalami in 
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responders while no significant thalamic activation in non-responders, 
which suggests that the significant bilateral strong activations (T > 11) in 
thalami are specifically linked to the restored consciousness (not the direct 
drug effect) as the drugs used in responders and non-responders are 
same. We also noticed that the bilateral cuneus were activated in 
responders while only left cuneus was activated in non-responders, which 
implied that physostigmine may activate the left cuneus but right cuneus 
activation is required to restore consciousness. 
For the four responders of this study, subjects were awake and the 
infusions of physostigmine and propofol were maintained during 
physostigmine condition. Therefore, a PHYSO minus BASE subtraction 
was generated to evaluate the effect of propofol and physostigmine, which 
is linked to the significant increasing of rCBF in the left thalamus, bilateral 
precental gyrus, right anterior cingulated gyrus, right medial frontal gyrus 
and other cortical areas. There is still a residual concentration of propofol 
and physostigmine in the body during the recovery condition. Therefore a 
RECO minus BASE subtraction was generated to evaluate the effect of 
residual propofol and physostigmine, which was linked to the significant 
increasing of rCBF in the left thalamus, bilateral precentral gyrus, left 
anterior cingulate gyrus, right medial frontal gyrus and other cortical areas. 
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Now we know that t~e effect of propofol and physostigmine is linked to the 
significant rCBF increase in the left thalamus, bilateral precentral gyrus, 
anterior cingulated gyrus, right medial frontal gyrus and other cortical 
areas. The next logical step was to differentiate the effect of propofol and 
effect of physostigmine. If propofol caused the significant rCBF increase in 
the left thalamus and precentral gyrus, a BASE minus UNCO subtraction 
could reveal similar changes in rCBF. In fact, a BASE minus UNCO 
subtraction revealed the significant decrease of rCBF in right thalamus 
and precuneus and non-significant decrease of rCBF in left thalamus (-17, 
-19, 14, T = 2.78) but no any rCBF increase, which T value is larger than 
2.5, in the left thalamus and precentral gyrus. Therefore, we can 
hypothesize that the direct effects of physostigmine are Iinked to the 
significant rCBF increase in left medial thalamus, bilateral precentral gyrus, 
anterior cingulated gyrus, and other cortical areas. Region-based 
regressions revealed that left thalamus was positive covariated with right 
thalamus, medial frontal gyrus, bilateral putamen, and left cuneus. 
Furthermore, the event regression revealed that rCBF in left thalamus is 
significantly positively co-variated the physostigmine-restored 
consciousness in subtraction PHYSO minus UNCO and PHYSO minus 
BASE. Based on above evidences, we hypothesize that physostigmine 
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restores consciousness by first activating the left thalamus and then the 
right thalamus and other cortical areas. The activations in both sides of 
thalami are essential for regaining consciousness. 
Furey et al. (2000A) assessed the time course of pharmacodynamie 
and pharmacokinetic effects of physostigmine using PET rCBF technique. 
They found that physostigmine did not affect resting rCBF in right 
prefrontal region but physostigmine significantly redueed rCBF in right 
prefrontal region during task, whieh is consistent with our finding of the 
significant reduction of rCBF in right middle frontal gyrus (Table 3-4). 
Because their goal was to deteet the task of working memory related rCBF 
changes, the subtraction between pre-infusion and after physostigmine 
infusion was not reported. In another study (Furey et aL, 2000B), They 
demonstrated that the negative correlations, indicating regions in which 
greater rCBF increases were associated with greater improvement in 
reaction time, were restricted to medial occipital visual cortex, suggesting 
that physostigmine may improve task performance by enhancing visual 
processing. We are not aware of any other previous human studies 
assessing the direct specifie effect of physostigmine on brain rCBF with 
which our results could be compared. 
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3.5.4 Conclusion 
ln conclusion, we have demonstrated that right thalamus and 
bilateral precuneus are specifically linked to propofol-induced 
unconsciousness, and ruled out a non-specifie effect of propofol on those 
brain areas. Thus, the results of our study support a hypothesis that the 
joint activation and deactivation of a Common Midline Core, which 
includes the medial thalamus, midline precuneus/cuneus, prefrontal cortex 
and other related cortical areas, contributed to the changes of level of 
consciousness. We also hypothesized that physostigmine restored 
consciousness by first activating the left thalamus and cuneus and then 
the right thalamus and cuneus and other cortical areas. Our data 
suggested that the activations in both sides of thalamus and cuneus may 
be essential for regaining consciousness. 
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Chapter 4 GENERAL DISCUSSION 
Immobility, amnesia, and unconsciousness are the three goals that 
must be achieved in adequate surgical anesthesia. The anesthetics may 
act on different regions of nervous system to produce these three goals. It 
has been known that immobilization is very likely mediated by effects on 
the spinal cord while amnesia is likely mediated by effects on the 
dorsolateral prefrontal cortex. The results of chapter 2 in thesis may 
indicate a propofol-related reduction in muscarinic receptor binding in CNS 
which supports a hypothesis that the loss of consciousness produced by 
propofol is mediated, at least in part, via interruption of central cholinergie 
muscarinic transmission. The results of chapter 3 in this thesis support a 
hypothesis that the joint deactivations of a Common Midline Core, which 
includes the medial thalamus, midline precuneus/cuneus, prefrontal cortex 
and other related cortical areas, contribute to the unconsciousness 
induced by general anesthetics. In order to fully explore the mechanism of 
unconsciousness induced by general anesthetics, we have to understand 
the molecular mechanisms of unconsciousness induced by general 
anesthetics and build a complete neurophysiological theory of the action 
of anesthetics to suppress consciousness. 
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4.1 Theoretical explanations of anesthetic action 
As experimental evidences contradicted the old lipophilicity 
hypothesis, which had dominated for more than one century, the work of 
Franks and Lieb (1984) shifted attention from lipids to proteins as 
anesthetic targets. They proposed that at the molecular level, anesthetics 
almost certainly act by binding directly to proteins, which are considered 
likely ta be postsynaptic ligand-gated channels (Franks and Lieb, 1994). 
Although some anesthetics might act at excitatory synapses, such as 
ketamine at NMDA receptors and some anesthetics potentiate inhibitory 
synaptic receptors, such as GABA receptors, both inhibition of excitory 
synapses and potentiation of inhibitory synapses may be involved in 
anesthetic effects. Anesthetics may act on a variety of neurotransmission 
processes, and the effects are widespread throughout the brain. Ion 
channel proteins integrated with other proteins into a membrane patch, 
patches are integrated into a nerve cell, nerve cells are integrated into 
networks, and local networks are integrated into functional units (John and 
Prichep, 2005). Therefore, it is not sufficient for a theory of anesthesia to 
be based on demonstration of some primary effects of an anesthetic drug 
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on neuron receptor~ or on some particular molecular or cellular sites of 
action. 
Flohr et al. (1998) proposed a theory that the conditions for 
consciousness state can be defined by a specific computational structure 
that gives rise to functional states that are identical with states of 
consciousness. It consists of four hypotheses. (1) The occurrence of 
states of consciousness depends on the formation of transient higher-
order, self-referential mental representations, which is identical with the 
appearance of consciousness. Loss of consciousness will occur when the 
brain's representational activity falls below a critical threshold. (2) Higher-
order mental representations are instantiated by neural cell assemblies. (3) 
The formation of such assemblies involves the activation of the NMDA 
receptor channel complex. The activation state of this receptor determines 
the rate at which such assemblies are generated. (4) Modification of 
NMDA-dependent computational processes is the final common pathway 
of anesthetic action. They proposed that the common mode of anesthetic 
action is the disruption of NMDA-dependent computational processes. 
Agents that directly inactivate the NMDA synapse necessarily have 
anesthetic properties; agents that do not directly affect the NMDA synapse 
will exert an anesthetic action by inhibiting NMDA-dependent processes. 
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The concepts from quantum physics have been used to explain the 
molecular basis of anesthetic action. Woolf and Hameroff (2001) have 
proposed that rudimentary visual consciousness depends on quantum 
computation in microtubules in the cytoplasmic interiors of cortical 
pyramidal dendrites interconnected by gap junctions. These interactions 
are critically dependent on cholinergie action on pyramidal cell dendrites 
and on GABAergic interneurons interconnected by electrotonic gap-
junction connections. Unfortunately such proposai remain theoretically 
controversial and without experimental support. 
4.2 The neurophysiologic theory of the action of anesthetics to suppress 
consciousnes 
Recordings from the surface of the scalp have long been known to 
demonstrate rhythmic voltage oscillations derived from the electrical 
activity of the subjacent neuronal population. With development of modern 
technology, we can use validated automatic editing algorithms ta rem ove 
contaminated signais that do not arise from brain electrical activity and we 
can use computer analysis to describe the power spectrum in each scalp 
region. For such quantitative electroencephalographic analyses, the 
quantitative electroencephalogram is conventionally divided into frequency 
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bands, approximately defined as 8 (0.5-4 Hz), e (4-8 Hz). Iowa (8-10 Hz), 
high a (10-12 Hz), ~ (12-25 Hz), and y (25-50 Hz). 
ln the thalamic relay nuclei, some types of neurons diaplay rhythmic 
oscillations in the frequency range of 6-10 Hz. This oscillatory behavior 
seems to be an intrinsic property of these neurons. The a activity arises 
from the interaction between populations of these neurons in the thalamus 
and in certain areas of the cortex. In the thalamic nuclei, three main types 
of neurons interact: thalamocortical relay (TeR) nuclei whose axons 
project to the cortex, reticular nucleus (RE) neurons that interact 
synaptically with the TeR cells and contribute GABAergic inhitory 
feedback control, and local intrinsic neurons (Steriade, 1993). By 
GABAergic action, RE neurons can act to diminish sensory throughput 
TeR neurons to the cortical receiving areas, slow the mean frequency of 
the oscillation and shifting the a rhythm toward e (4-8 Hz). The diminished 
activation of the cortex by thalamus and the ascending reticular activation 
system (ARAS) results in the production of a very slow rhythm called 8 
activity (0.5-4 Hz). The corticocortical interactions generate the ~ rhythm 
(12-25 Hz). The feedback from the corticothalamic volley binds the 
distributed fragments and causes coherent corticothalamocortical loops to 
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reverberate at the frequency of the y rhythm (25-50 Hz) (John and Prichep, 
2005). 
Sased on intracerebral recordings, Desmedt and Tomberg (1994) 
have reported that a brief period of y activity with zero phase lag appears 
coherently between prefrontal cortex and parital cortex of human subjects 
during preformance of perceptual tasks. Their findings are consistent with 
the suppression of prefrontal cortex and precuneus/cuneus during 
unconsciousness induced by general anesthetics. After reviewing the 
recent consciousness-related researches, John and Prichep (2005) 
propose that the neurophysiological effects that produce amnesia and 
unconsciousness induced by general anesthetics occur in six steps: (1) 
depression of the brainstem reduces the influences of the ARAS on the 
thalamus and cortex; (2) depression of mesolimbic-dorsolateral prefrontal 
cortex interactions leads to blockade of memory storage; (3) further 
depression of the ARAS releases its inhibition of the nucleus reticularis of 
the thalamus, resulting in c10sure of thalamus gates by hyperpolarizing 
GABA-mediated inhibitory action of the nucleus reticularis (8 increase), 
thereby blocking; (4) thalamocorticothalamocortical reverberations and 
perception (y decrease); (5) parital-frontal transactions are uncoupleed (y 
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coherence decrease), blocking cognition; (6) prefrontal cortex is 
depressed to reduce awareness (Figure 4-1). 
4.3 Funetional brain imaging evidenee of the neurophysiologie theory 
General anesthetics that cause depression of the ARAS in the 
brainstem can reduce activating and arousal influences on the specifie 
and nonspecific thalamic nuclei and cortex. Fiset et al. (1999) found that 
there was significant eovariation between the thalamic and midbrain blood 
flow during unconscousnes induced by propofol, which is consistent with 
the role of the thalamus and the ARAS. Ogawa et al. (2003) reported that 
significant decreases in rCBF oceured in the pontine tegmentum during 
propofol anesthesia. The significant deactivations were found in midbrain 
during unconsciousness induced by propofol (Kaisti et aL, 2002) , 
isoflurane and halothane (Alkire et aL, 2000). Ali above evidence of brain 
imaging demonstrated that the brain stem was suppressed during the 
anesthetic-induced unconsciousness. 
Depression of the ARAS can release complex GABAergic inhibitory 
effects in the Iimbic system due to diminution of ARAS inputs that 
produce cholinergie inhibition of GABA. General ansthetics may 
diminishes the interactions of the mesolimbic circuits, including the 
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Figure 4-1: Schematic depiction of six stages hypothesized to explain the 
unconsciousness induced by general anesthetics. 
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reticularis, resulting in closure thalamic gates and leading to step 4: 
blockade of reverberations in corticothalamocortical loops and interruption 
of resonance, causing step 5: uncoupling of parietal-prefrontal cortical 
interaction, resulting in step 6: depression of prefrontal cortex with 
unconsciousness. (From Zeman 1997) 
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amygdala, hippocampus-cingulate cortex with the dorsolateral prefrontal 
cortex, to block the storage of memory and achieve amnesia. Sperling et 
al. (2002) revealed that the significant decreases were observed in both 
the extent and magnitude of activation within the hippocampal, fusiform, 
and inferior prefrontal ROis with the administration of either lorazepam or 
scopolamine. Unfortunately most of PET studies failed to detect significant 
rCBF reduction in limbic system during the unconsciousness induced by 
general anesthetics. It may indicate that the inhibitory eftects in the limbic 
system caused the minor rCBF response. 
The depression of brainstem releases the nucleus reticularis form the 
inhibiting influence of the ARAS, which can lead to closure of thalamic 
gates due to the inhibitory action of nucleus reticularis, resulting in 
diminished cortical input. Decreased thalamocortical input may result 
either by loss of activation from the ARAS or by dynamic inhibition via 
nucleus reticularis. Inhibition of either the cortex or thalamic projection 
nuclei blocks the corticothalamocortical reverberations that are 
hypothesized to be critcal for consciousness. The thalamical inhibitions 
were demonstrated during anesthetic-induced unconsciousness in most 
brain imaging study. The BASE-UNCO subtraction of this study and other 
two studies (Bonhomme et aL, 2001, Veselis et aL, 1997B) have revealed 
147 
that general anesthetics significantly decreased the rCBF of the right 
medial dorsal nucleus of thalamus, which is closely related to the frontal 
association cortex and this pathway is reported to maintain vigilance and 
working memory (Kinomura et aL, 1996). Although the nucleus of 
thalamus deactiveated in different stuides were different, the deactivation 
of thalamus were detected during anesthetic-induced unconsciousnes in 
most imaging studies. 
Depression of the parietal cortex interrupt the prefrontal-parietal 
transactions critical for perception. Inhibition of the prefrontal cortex 
releases its modulation of nucleus reticularis, resulting in defocusing of 
attention and reducing activation of the systems medicating speech and 
movement. This part of theory is strongly supported by results from 
functional brain imaging studies. In the auditory vigilance task, large 
increases in rCBF were observed in the ventrolateral prefrontal cortex (BA 
45, 47) as compared with the baseline state (Paus, 1997). This finding is 
consistent with the results of lesion study (Wilkins et al., 1987) and 
supports a role of the prefrontal lobe in the allocation of the capacity-
limited attention mechanisms. Dorsolateral prefrontal cortex was activated 
during working memory (Carpenter and Just, 2000). The precuneus 
(medial parietal cortex) has been identified as a major contributor to two 
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relaxed conscious states: normal resting consciousness and the relaxation 
meditation in Yogo Nidra (Lou et aL, 1999; Kjaer and Lou, 2000). The 
precuneus/posterior cingulate regions has repeatly been associated with 
episodic memory retrieval (Cabeza ànd Nyberg, 2000). These studies 
highlighted the importance of precuneus for maintaining normal conscious 
state. In both deep SWS and REM sleep, significant deactivations were 
seen in precuneus (Marquet et al., 1997). Thus, reduction in activity in the 
precuneus is common to the two types of sleep, which again emphasizes 
the importance of precuneus for maintaining normal conscious state. 
During the unconsciousness induced by general anesthetics, the 
attention, awareness, and working memory are ail lost. Therefore, it is not 
surprising to see the deactivation in the different areas of the prefrontal 
cortex and precuneus. Both the prefrontal areas and precuneus were 
deactivated du ring the unconsciousness induced by general anesthetics in 
most functional brain imaging studies. The region-based regression 
analysis of right thalamus suggested a close functional relationship 
between right thalamus and bilateral precuneus and cuneus. The region-
based regression analysis of left thalamus suggested a close functional 
relationship between left thalamus and right medial frontal gyrus. Both 
results indicate that the interruption of prefrontal-parietal transactions is 
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related to the deactiyation of right thalamus while restoration of prefrontal-
parietal transactions related to activation of bilateral thalami. Furthermore, 
the first study of this thesis demonstrated the significant reduction of 
muscarinic receptor availability in orbital-frontal cortex and parietal cortex. 
These results may suggest that the interruption of prefrontal-parietal 
transactions is caused by the depression of cholinergie system. 
4.4 Theory about consciousness restored by physostigmine 
We have hypothesized that the joint deactivities of a Common 
Midline Core, which includes the medial thalamus, midline 
precuneus/cuneus, prefrontal cortex and other related cortical areas, are 
contributed to the unconsciousness induced by general anesthetics. This 
hypothesis is consistent with the neurophysiologie theory of John and 
Prichep. Thus, we hypothesize that the consciousness restored by 
physostigmine involved similar neuronal network but slightly difterent 
structures. The consciousnes restored by physostigmine related to not 
only activation in right thalamus but also the activation in the left thalamus. 
The bilateral cuneus were activated in the consciousness restored by 
physostigmine while the bilateral precuneus were deactivated during the 
propofol-induced unconsciouseness. Comparing the results of PHYSO 
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minus UNCO of four responders and three non-responders, we can see 
the activations in bilateral thalami in responders while no significant 
thalamic activation in non-responders, which suggests that the significant 
bilateral strong activations (T > 11) in thalami are specifically linked to the 
restored consciousness (not the direct drug effect) as the drugs used in 
responders and non-responders are same. We also notice that the 
bilateral cuneus are activated in responders while only left cuneus was 
activated in non-responders, which imply that physostigmine may activate 
the left cuneus but right cuneus activation is required to restore 
consciousness. 
From discussion of 3.5.3.2, we know that the direct effects of 
physostigmine are linked to the significant rCBF increase in left medial 
thalamus, bilateral precentral gyrus, anterior cingulated gyrus, and other 
cortical areas. Region-based regressions revealed that left thalamus was 
positively covariated with right thalamus, medial frontal gyrus, bilateral 
putamen, and left cuneus. Furthermore, the event regression revealed that 
rCBF in left thalamus is significantly positive co-variated the 
physostigmine-restored consciousness in subtraction PHYSO minus 
UNCO and PHYSO minus BASE. Based on above evidences, we 
hypothesize that physostigmine restore consciousness by first activating 
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the left thalamus and then the right thalamus and other cortical areas. The 
activations in both sides of thalami are essential for regaining 
consciousness. 
Based on above results, 3 stages were hypothesized to explain the 
consciousness restored by physostigmine. Step 1: activation of left 
thalamus, left cuneus and reticular formation, resulting in step 2: activation 
of right thalamus and cuneus, reaching certain threshold of right thalamus 
and cuneus, and cause cuneusthalamical reverberations, causing step 3: 
activation of prefrontal cortex to restore the consciousness (Figure 4-2). If 
the activation of right thalamus and cuneus do not reach the threshold, the 
cuneusthalamical reverberations will not happen, and the subject will not 
regain consciousness after infusion of physostigmine. 
4.4 General conclusion 
The understanding of states of consciousness has been identified as 
an outstanding intellectual challenge across disciplines ranging from 
neuroscience through psychology to anesthesiology. The advent of 
functional imaging combined with sophisticated electroencephalographic 
techniques is transforming our ability to study the state of consciousness 
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Figure 4-2: Schematic depiction of 3 stages hypothesis to explain the 
consciousness restored by physostigmine 
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Prefrontal 
cortex 
• 
Right 
cuneus 
Right 
thalamus 
• 1 1 
Reticular formation 
Left 
cuneus 
Left 
thalamus 
Step 1: activation of left thalamus, left cuneus and reticular formation, 
resulting in step 2: activation of right thalamus and cuneus, reach 
threshold of right thalamus and cuneus, cause cuneusthalamical 
reverberations, causing step 3: activation of prefrontal cortex 
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directly in humans .. With functional brain imaging, the studies in normal 
conscious state, sleep, and anesthetic-induced unconsciousness 
demonstrate the critical raie of thalamus and precuneus/cuneus in 
maintaining and losing the state of consciousness. Based on our second 
study, we hypothesized that the joint deactivations of a Common Midline 
Core, which includes the medial thalamus, midline precuneus/cuneus, 
prefrantal cortex and other related cortical areas, contribute to 
unconsciousness induced by general anesthetics. These joint 
deactivations disrupt the functional interaction within the thalamocortical 
and corticocortical neural networks. We also hypothesize that 
physostigmine restore consciousness by first activating the left thalamus 
and cuneus and then the right thalamus, cuneus, and other cortical areas. 
The activations in both sides of thalamus and cuneus may be essential for 
regaining consciousness. 
The first study of this thesis demonstrates that propofol praduced a 
decrease in central acetylcholine bindings in several brain regions rich in 
muscarinic receptors. This finding suggests that depression of central 
cholinergie transmission is one of the common pathways mediating 
anesthesia-induced unconsciousness. The findings of both studies have 
significant relevance for current theories of consciousness and provide 
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additional insight into the potential mechanisms of unconsciousness 
induced by general anesthetics. 
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